https://novapharmanews.com/apac/news/xtalpi-pep08-prmt5-inhibitor-phase-1-cancer-trial-enrollment 2026-05-04T21:17:29.885Z monthly 0.6 https://novapharmanews.com/apac/news/spontan-phase-ii-data-10-minute-onset-fda-requirements-erectile-dysfunction 2026-05-04T22:16:00.252Z monthly 0.6 https://novapharmanews.com/apac/news/ironwood-pharmaceuticals-short-bowel-syndrome-tpn-survey-ddw-2026 2026-05-04T22:16:18.531Z monthly 0.6 https://novapharmanews.com/apac/news/edwards-lifesciences-resilia-tissue-10-year-commence-trial-results 2026-05-04T22:16:16.785Z monthly 0.6 https://novapharmanews.com/apac/news/novo-nordisk-wegovy-china-launch-eli-lilly-obesity-market 2026-05-04T22:37:24.500Z monthly 0.6 https://novapharmanews.com/apac/news/arrowhead-pharmaceuticals-tga-approval-redemplo-plozasiran-australia-fcs 2026-05-04T21:15:28.387Z monthly 0.6 https://novapharmanews.com/apac/news/biomarin-palynziq-fda-approval-adolescent-pku-patients 2026-05-04T21:15:04.650Z monthly 0.6 https://novapharmanews.com/apac/news/rois-us-expansion-global-cdmo-fda-approval-injectable-manufacturing 2026-05-04T22:15:08.575Z monthly 0.6 https://novapharmanews.com/apac/news/fda-approves-travere-filspari-fsgs-treatment-adults-children 2026-05-04T21:14:09.600Z monthly 0.6 https://novapharmanews.com/eu/news/vanda-pharmaceuticals-nereus-tradipitant-motion-sickness-drug-launch 2026-05-04T22:16:02.517Z monthly 0.6 https://novapharmanews.com/eu/news/takeda-tak-881-phase-3-trial-primary-immunodeficiency-disease-results 2026-05-04T21:13:28.315Z monthly 0.6 https://novapharmanews.com/eu/news/pulse-biosciences-atrial-fibrillation-treatment-100-percent-success-rate-2026 2026-05-04T23:05:59.594Z monthly 0.6 https://novapharmanews.com/eu/news/sq-innovation-lasix-onyu-subcut-hf-ii-trial-results-heart-failure-2026 2026-05-04T22:14:01.611Z monthly 0.6 https://novapharmanews.com/eu/news/krystal-biotech-q1-2026-results-vyjuvek-expansion-registrational-studies 2026-05-04T22:16:06.587Z monthly 0.6 https://novapharmanews.com/eu/news/acurx-dna-pol-iiic-inhibitors-microbiome-preservation-mrsa-escmid-2026 2026-05-04T23:05:58.685Z monthly 0.6 https://novapharmanews.com/eu/news/biocryst-navenibart-european-licensing-deal-neopharmed-gentili 2026-05-04T21:11:34.136Z monthly 0.6 https://novapharmanews.com/eu/news/biosimulation-market-11-billion-2031-drug-development 2026-05-04T22:29:12.651Z monthly 0.6 https://novapharmanews.com/eu/news/grin-therapeutics-phase-3-beeline-study-radiprodil-europe-grin-ndd 2026-05-04T22:14:49.240Z monthly 0.6 https://novapharmanews.com/eu/news/fda-approves-langlara-biosimilar-lantus-insulin-lannett-company 2026-05-04T21:10:15.364Z monthly 0.6 https://novapharmanews.com/eu/news/vertex-casgevy-gene-therapy-global-expansion-q1-2026-results 2026-05-04T21:09:44.026Z monthly 0.6 https://novapharmanews.com/eu/news/oncolytics-biotech-pelareorep-durable-responses-ras-mutant-colorectal-cancer 2026-05-04T22:16:01.173Z monthly 0.6 https://novapharmanews.com/eu/news/nuvation-bio-ibtrozi-q1-2026-revenue-ros1-nsclc 2026-05-04T22:33:08.005Z monthly 0.6 https://novapharmanews.com/us/news/crispr-therapeutics-casgevy-global-approvals-60000-patients 2026-05-04T22:16:11.386Z monthly 0.6 https://novapharmanews.com/us/news/clene-cnm-au8-fda-accelerated-approval-pathway-als-treatment 2026-05-04T22:16:14.374Z monthly 0.6 https://novapharmanews.com/us/news/atossa-therapeutics-fda-rare-pediatric-disease-designation-z-endoxifen-mccune-albright-syndrome 2026-05-04T22:46:39.830Z monthly 0.6 https://novapharmanews.com/us/news/mbiota-elemental-ibs-treatment-ddw-2026-clinical-trial 2026-05-04T22:29:42.129Z monthly 0.6 https://novapharmanews.com/us/news/novartis-fabhalta-health-canada-approval-c3g-treatment 2026-05-04T21:06:46.384Z monthly 0.6 https://novapharmanews.com/us/news/asco-2026-cellectar-waldenstrom-macroglobulinemia 2026-05-04T22:28:21.102Z monthly 0.6 https://novapharmanews.com/us/news/alpha-tau-alpha-dart-pancreatic-cancer-trials-ddw-2026 2026-05-04T21:06:20.926Z monthly 0.6 https://novapharmanews.com/us/news/cytokinetics-aficamten-phase-3-trial-results-non-obstructive-hypertrophic-cardiomyopathy-may-2026 2026-05-04T22:45:16.199Z monthly 0.6 https://novapharmanews.com/us/news/inflarx-izicopan-reactive-metabolite-liver-safety-study 2026-05-04T21:05:22.655Z monthly 0.6 https://novapharmanews.com/us/news/macrogenics-expands-zynyz-royalty-agreement-sagard-healthcare 2026-05-04T22:16:16.017Z monthly 0.6 https://novapharmanews.com/us/news/akebia-vadadustat-mortality-reduction-kidney-disease-jasn-study 2026-05-04T22:16:17.833Z monthly 0.6 https://novapharmanews.com/us/news/inflarx-izicopan-favorable-liver-metabolism-safety-profile-2026 2026-05-04T22:14:38.295Z monthly 0.6 https://novapharmanews.com/us/news/celcuity-gedatolisib-phase-3-viktoria-1-trial-pik3ca-mutant-cancer 2026-05-04T22:13:53.345Z monthly 0.6 https://novapharmanews.com/us/news/fda-approves-langlara-interchangeable-biosimilar-lantus-insulin-lannett 2026-05-04T23:05:58.138Z monthly 0.6 https://novapharmanews.com/us/news/fda-approves-guardant360-cdx-companion-diagnostic-pfizer-veppanu-breast-cancer 2026-05-04T21:03:52.357Z monthly 0.6 https://novapharmanews.com/us/news/fda-approves-incyte-jakafi-xr-extended-release-myelofibrosis 2026-05-04T21:01:50.675Z monthly 0.6 https://novapharmanews.com/us/news/arvinas-veppanu-vepdegestrant-fda-approval-first-protac-drug-esr1-breast-cancer 2026-05-04T22:16:12.881Z monthly 0.6 https://novapharmanews.com/us/news/excipient-world-conference-daily-roundup 2026-05-04T22:08:47.903Z monthly 0.6 https://novapharmanews.com/us/news/APHL-2026-annual-meeting-day-1-highlights 2026-05-04T22:14:09.625Z monthly 0.6 https://novapharmanews.com/us/news/aphl-2026-day-1-roundup 2026-05-04T23:05:57.485Z monthly 0.6 https://novapharmanews.com/eu/news/swiss-biotech-day-daily-roundup 2026-05-04T22:16:10.531Z monthly 0.6 https://novapharmanews.com/apac/news/fda-approves-auvelity-new-mdd-treatment 2026-05-04T12:48:55.588Z monthly 0.6 https://novapharmanews.com/apac/news/sun-pharma-organon-partnership-india 2026-05-04T12:49:12.653Z monthly 0.6 https://novapharmanews.com/eu/news/fda-approves-auvelity-mdd-axsome-therapeutics 2026-05-04T12:48:55.544Z monthly 0.6 https://novapharmanews.com/eu/news/purdue-pharma-shutdown-oxycontin-settlement 2026-05-04T22:01:31.661Z monthly 0.6 https://novapharmanews.com/us/news/fda-approves-palazestrant-pfizer-arvinas-breast-cancer-drug 2026-05-04T22:10:22.978Z monthly 0.6 https://novapharmanews.com/eu/news/eular-2026-immutep-imp761-phase-1-preview 2026-05-04T22:39:40.535Z monthly 0.6 https://novapharmanews.com/us/news/thma-pharmacy-growth-priorities-2026 2026-05-04T22:08:04.160Z monthly 0.6 https://novapharmanews.com/us/news/cphi-americas-2026-pharma-manufacturing-trends 2026-05-04T12:49:12.169Z monthly 0.6 https://novapharmanews.com/us/news/ipec-americas-annual-meeting-daily-roundup 2026-05-04T22:42:50.137Z monthly 0.6 https://novapharmanews.com/us/news/excipient-world-conference-day-1-highlights 2026-05-04T22:44:46.256Z monthly 0.6 https://novapharmanews.com/us/news/aphl-2026-annual-day-1-roundup 2026-05-04T22:14:00.567Z monthly 0.6 https://novapharmanews.com/apac/news/ucb-acquires-candid-therapeutics-2-2-billion-t-cell-engager-autoimmune 2026-05-04T12:49:12.654Z monthly 0.6 https://novapharmanews.com/eu/news/novelty-nobility-agc-biologics-bispecific-antibody-manufacturing-partnership 2026-05-04T12:49:12.260Z monthly 0.6 https://novapharmanews.com/eu/news/smartee-denti-technology-mandibular-repositioning-eas-congress-2026 2026-05-04T12:52:21.371Z monthly 0.6 https://novapharmanews.com/us/news/xtalpi-pep08-prmt5-inhibitor-phase-1-cancer-trial-enrollment 2026-05-04T22:43:00.624Z monthly 0.6 https://novapharmanews.com/us/news/mirum-pharmaceuticals-vistas-volixibat-primary-sclerosing-cholangitis-results-may-2026 2026-05-04T22:14:46.402Z monthly 0.6 https://novapharmanews.com/us/news/everads-therapy-suprachoroidal-injector-clinical-data-ophthalmology-science 2026-05-04T22:08:43.897Z monthly 0.6 https://novapharmanews.com/us/news/ucb-acquires-candid-therapeutics-autoimmune-deal 2026-05-04T14:00:17.214Z monthly 0.6 https://novapharmanews.com/us/news/spinogenix-tazbentetol-neuroprotective-glaucoma-diabetic-retinopathy-arvo-2026 2026-05-04T22:16:01.817Z monthly 0.6 https://novapharmanews.com/us/news/niktimvo-axatilimab-approved-australia-chronic-gvhd-treatment 2026-05-04T22:45:54.460Z monthly 0.6 https://novapharmanews.com/us/news/ipec-annual-meeting-2026-no-pharma-news 2026-05-04T12:49:29.867Z monthly 0.6 https://novapharmanews.com/eu/news/swiss-biotech-day-2026-ai-oncology-microbiome 2026-05-04T12:49:41.664Z monthly 0.6 https://novapharmanews.com/us/news/excipient-world-conference-2026-daily-roundup 2026-05-04T12:50:11.435Z monthly 0.6 https://novapharmanews.com/us/news/aphl-2026-annual-meeting-opens-public-health-lab-focus 2026-05-04T12:50:11.471Z monthly 0.6 https://novapharmanews.com/apac/news/fda-approves-auvelity-mdd-new-antidepressant 2026-05-04T22:44:50.234Z monthly 0.6 https://novapharmanews.com/eu/news/purdue-pharma-dissolution-approved-opioid-crisis 2026-05-04T21:12:23.950Z monthly 0.6 https://novapharmanews.com/eu/news/auvelity-fda-approval-axsome-therapeutics 2026-05-04T21:12:32.847Z monthly 0.6 https://novapharmanews.com/us/news/axsome-fda-approval-alzheimers-agitation 2026-05-04T22:10:12.968Z monthly 0.6 https://novapharmanews.com/us/news/fda-approves-first-non-antipsychotic-dementia-agitation 2026-05-04T22:16:12.168Z monthly 0.6 https://novapharmanews.com/apac/news/a2-milk-company-recalls-platinum-infant-formula-health-risk 2026-05-04T22:16:15.122Z monthly 0.6 https://novapharmanews.com/us/news/edwards-lifesciences-resilia-tissue-10-year-durability-aortic-valve-trial 2026-05-04T21:23:29.793Z monthly 0.6 https://novapharmanews.com/us/news/biomarin-voxzogo-achondroplasia-long-term-data-pes-2026 2026-05-04T20:13:02.073Z monthly 0.6 https://novapharmanews.com/us/news/fda-approves-incyte-jakafi-xr-extended-release-myelofibrosis-polycythemia-vera 2026-05-04T23:06:00.219Z monthly 0.6 https://novapharmanews.com/apac/news/fda-approves-auvelity-axsome-therapeutics-mdd 2026-05-04T20:04:58.952Z monthly 0.6 https://novapharmanews.com/eu/news/fda-approves-auvelity-for-major-depressive-disorder 2026-05-04T19:50:43.155Z monthly 0.6 https://novapharmanews.com/us/news/plozasiran-tga-approval-australia-redemplo-fcs 2026-05-04T22:33:18.013Z monthly 0.6 https://novapharmanews.com/apac/news/vector-science-therapeutics-microneedle-catheter-patent-intratumoral-drug-delivery 2026-05-04T21:02:46.884Z monthly 0.6 https://novapharmanews.com/apac/news/apotex-generic-ozempic-semaglutide-health-canada-approval-2026 2026-05-04T22:49:42.611Z monthly 0.6 https://novapharmanews.com/apac/news/keenova-terlivaz-terlipressin-clinical-data-digestive-disease-week-2026 2026-05-04T21:11:23.905Z monthly 0.6 https://novapharmanews.com/apac/news/kodiak-sciences-ksi-101-clinical-data-macular-edema-conferences 2026-05-04T22:29:02.641Z monthly 0.6 https://novapharmanews.com/eu/news/synbiotech-microbiome-womens-healthy-aging-vitafoods-2026 2026-05-04T12:52:21.434Z monthly 0.6 https://novapharmanews.com/eu/news/curaleaf-torsten-greif-board-appointment-european-cannabis 2026-05-04T12:52:21.467Z monthly 0.6 https://novapharmanews.com/eu/news/pharmaceutical-manufacturing-software-market-787-billion-2030 2026-05-04T18:53:00.257Z monthly 0.6 https://novapharmanews.com/eu/news/goodrx-ozempic-pill-type-2-diabetes-149-monthly 2026-05-04T18:27:08.648Z monthly 0.6 https://novapharmanews.com/us/news/neurocrine-crenessity-two-year-pediatric-cah-study-results 2026-05-04T22:23:08.653Z monthly 0.6 https://novapharmanews.com/us/news/cairn-surgical-breast-cancer-locator-system-pivotal-trial-results 2026-05-04T22:59:10.440Z monthly 0.6 https://novapharmanews.com/us/news/restore-vision-rv-001-gene-therapy-retinitis-pigmentosa-clinical-results 2026-05-04T22:46:55.856Z monthly 0.6 https://novapharmanews.com/us/news/archimed-acquires-esperion-therapeutics-cardiometabolic-deal-2026 2026-05-04T21:26:43.964Z monthly 0.6 https://novapharmanews.com/us/news/oculis-dme-research-arvo-2026-presentation 2026-05-04T21:24:54.740Z monthly 0.6 https://novapharmanews.com/us/news/rhythm-pharmaceuticals-imcivree-european-commission-approval-hypothalamic-obesity 2026-05-04T21:51:44.095Z monthly 0.6 https://novapharmanews.com/us/news/atara-biotherapeutics-ebvallo-fda-complete-response-letter-securities-lawsuit 2026-05-04T22:26:54.998Z monthly 0.6 https://novapharmanews.com/us/news/vanda-pharmaceuticals-nereus-tradipitant-motion-sickness-drug-available 2026-05-04T19:38:35.619Z monthly 0.6 https://novapharmanews.com/us/news/novo-nordisk-oral-ozempic-fda-approved-pill-glp1-type-2-diabetes-cardiovascular 2026-05-04T19:02:52.514Z monthly 0.6 https://novapharmanews.com/us/news/zeta-surgical-fda-clearance-brain-surgery-navigation-system 2026-05-04T22:42:16.269Z monthly 0.6 https://novapharmanews.com/us/news/viatris-low-dose-estrogen-contraceptive-patch-acog-2026 2026-05-04T21:22:26.970Z monthly 0.6 https://novapharmanews.com/us/news/axsome-auvelity-fda-approval-alzheimers-agitation-treatment 2026-05-04T22:46:57.223Z monthly 0.6 https://novapharmanews.com/us/news/incyte-jakafi-xr-fda-approval-myelofibrosis-polycythemia-vera-gvhd 2026-05-04T22:26:20.103Z monthly 0.6 https://novapharmanews.com/us/news/arvinas-fda-approval-veppanu-vepdegestrant-protac-esr1-breast-cancer 2026-05-04T21:06:14.731Z monthly 0.6 https://novapharmanews.com/apac/news/plozasiran-tga-approval-australia-redemplo-fcs 2026-05-04T22:46:04.151Z monthly 0.6 https://novapharmanews.com/eu/news/plozasiran-tga-approval-australia-fcs 2026-05-04T21:20:41.448Z monthly 0.6 https://novapharmanews.com/us/news/moderna-fda-talks-phase-4-covid-vaccine-data 2026-05-04T22:29:34.666Z monthly 0.6 https://novapharmanews.com/us/news/the-common-fund-data-ecosystem-cfde-449d7791 2026-05-04T19:55:34.588Z monthly 0.6 https://novapharmanews.com/apac/news/namsa-lexitas-partnership-ophthalmic-medical-device-development 2026-05-04T12:52:26.573Z monthly 0.6 https://novapharmanews.com/apac/news/verified-clinical-trials-chubb-partnership-patient-safety-data-quality 2026-05-04T12:52:27.000Z monthly 0.6 https://novapharmanews.com/apac/news/huahui-health-beone-medicines-hh160-trispecific-antibody-oncology-partnership 2026-05-04T19:53:34.557Z monthly 0.6 https://novapharmanews.com/apac/news/amgen-q1-2026-financial-results-double-digit-growth 2026-05-04T22:53:23.366Z monthly 0.6 https://novapharmanews.com/apac/news/haier-biomedical-international-revenue-growth-2025 2026-05-04T18:29:00.593Z monthly 0.6 https://novapharmanews.com/apac/news/tga-combination-boundary-products-guidance-apac-pharmaceutical 2026-05-04T12:52:27.920Z monthly 0.6 https://novapharmanews.com/apac/news/genprex-israel-patent-reqorsa-gene-therapy-pd1-antibodies-cancer 2026-05-04T22:32:58.000Z monthly 0.6 https://novapharmanews.com/apac/news/prolacta-human-milk-fortifiers-prescription-drug-status-japan-jasmine-trial 2026-05-04T18:31:54.363Z monthly 0.6 https://novapharmanews.com/eu/news/stoke-therapeutics-zorevunersen-dravet-syndrome-q1-2026-results 2026-05-04T19:51:56.983Z monthly 0.6 https://novapharmanews.com/eu/news/uniqure-amt-130-gene-therapy-uk-approval-huntingtons-disease 2026-05-04T19:54:23.662Z monthly 0.6 https://novapharmanews.com/eu/news/northwest-biotherapeutics-annalisa-jenkins-dcvax-cancer-vaccine-adviser 2026-05-04T19:50:44.577Z monthly 0.6 https://novapharmanews.com/eu/news/cerus-intercept-blood-system-european-regulatory-review-phase-3-trials 2026-05-04T18:33:05.969Z monthly 0.6 https://novapharmanews.com/eu/news/bio-rad-q1-2026-ivdr-compliance-costs-european-diagnostics 2026-05-04T18:02:13.919Z monthly 0.6 https://novapharmanews.com/eu/news/fda-advisory-committee-recommends-astrazeneca-truqap-pten-deficient-prostate-cancer 2026-05-04T12:54:06.211Z monthly 0.6 https://novapharmanews.com/eu/news/alkeus-gildeuretinol-stargardt-disease-arvo-2026-data 2026-05-04T21:50:27.622Z monthly 0.6 https://novapharmanews.com/eu/news/setpoint-medical-multiple-sclerosis-trial-neuroimmune-therapy 2026-05-04T12:54:06.588Z monthly 0.6 https://novapharmanews.com/eu/news/emergent-biosolutions-q1-2026-financial-results 2026-05-04T20:58:07.259Z monthly 0.6 https://novapharmanews.com/eu/news/telix-tlx101-px-pixlumi-brain-cancer-imaging-european-approval 2026-05-04T18:49:15.854Z monthly 0.6 https://novapharmanews.com/us/news/mrm-health-mh002-fda-fast-track-ulcerative-colitis 2026-05-04T12:50:36.788Z monthly 0.6 https://novapharmanews.com/us/news/cadrenal-therapeutics-cad-1005-fda-phase-3-heparin-induced-thrombocytopenia 2026-05-04T19:55:15.804Z monthly 0.6 https://novapharmanews.com/us/news/redhill-rhb-204-comparable-efficacy-rhb-104-crohns-disease-map-treatment 2026-05-04T12:50:36.800Z monthly 0.6 https://novapharmanews.com/us/news/phathom-pharmaceuticals-voquezna-q1-2026-earnings-profitability-guidance 2026-05-04T12:53:07.996Z monthly 0.6 https://novapharmanews.com/us/news/contineum-therapeutics-pipe-791-positive-phase-1b-chronic-pain-results 2026-05-04T17:25:07.166Z monthly 0.6 https://novapharmanews.com/us/news/summit-therapeutics-ivonescimab-overall-survival-lung-cancer-asco-2026 2026-05-04T20:46:39.366Z monthly 0.6 https://novapharmanews.com/us/news/ac-immune-aci-24-alzheimers-trial-final-cohort-aci-19764-phase-1 2026-05-04T12:50:27.320Z monthly 0.6 https://novapharmanews.com/us/news/addex-dipraglurant-brain-injury-recovery-2025-results 2026-05-04T12:50:27.903Z monthly 0.6 https://novapharmanews.com/us/news/ac-immune-final-cohort-abate-trial-anti-abeta-alzheimer-treatment 2026-05-04T20:03:55.360Z monthly 0.6 https://novapharmanews.com/us/news/mabwell-9mw2821-cervical-cancer-esmo-gc-2026 2026-05-04T12:50:18.678Z monthly 0.6 https://novapharmanews.com/us/news/aquestive-therapeutics-securities-fraud-lawsuit-anaphylm-fda-review 2026-05-04T19:53:30.080Z monthly 0.6 https://novapharmanews.com/us/news/immunitybio-ibrx-fda-warning-letter-ankt-lawsuit-2026 2026-05-04T08:28:54.190Z monthly 0.6 https://novapharmanews.com/us/news/fda-advisory-committee-recommends-astrazeneca-truqap-pten-deficient-prostate-cancer 2026-05-04T18:34:31.097Z monthly 0.6 https://novapharmanews.com/us/news/eli-lilly-foundayo-orforglipron-fda-approval-obesity-q1-2026-results 2026-05-04T22:40:24.201Z monthly 0.6 https://novapharmanews.com/us/news/theradaptive-fda-approval-osteoadapt-sp-phase-3-spinal-fusion-trial 2026-05-04T07:27:26.835Z monthly 0.6 https://novapharmanews.com/eu/news/eu-biopharma-clinical-trials-ai-gene-therapy 2026-05-04T12:57:48.570Z monthly 0.6 https://novapharmanews.com/us/news/pharma-partnering-us-q1-2026-licensing-deals 2026-05-04T12:54:04.252Z monthly 0.6 https://novapharmanews.com/us/news/fierce-biotech-week-2026-ai-oncology-preview 2026-05-04T17:48:57.695Z monthly 0.6 https://novapharmanews.com/us/news/ipec-excipient-world-biologics-summit-2026-preview 2026-05-04T22:32:53.235Z monthly 0.6 https://novapharmanews.com/apac/news/axoft-55m-series-a-brain-computer-interface-clinical-trials 2026-05-04T19:48:05.791Z monthly 0.6 https://novapharmanews.com/apac/news/vivacta-bio-50-million-series-a-funding-gt801-car-t-therapy 2026-05-04T22:33:04.005Z monthly 0.6 https://novapharmanews.com/apac/news/taimei-technology-ai-clinical-trials-biokorea-2026 2026-05-03T21:20:52.779Z monthly 0.6 https://novapharmanews.com/apac/news/energenesis-energi-f703dfu-diabetic-foot-ulcer-ewma-2026 2026-05-03T23:20:27.293Z monthly 0.6 https://novapharmanews.com/apac/news/ascletis-pharma-diabetes-drug-data-ada-2026-scientific-sessions 2026-05-04T17:26:33.197Z monthly 0.6 https://novapharmanews.com/apac/news/tlx597-tx-psma-radioligand-therapy-optimal-trial-prostate-cancer 2026-05-04T21:37:47.798Z monthly 0.6 https://novapharmanews.com/apac/news/immunitybio-securities-fraud-lawsuit-anktiva-fda-warning-letter 2026-05-04T21:31:50.193Z monthly 0.6 https://novapharmanews.com/eu/news/hutchmed-sovleplenib-priority-review-breakthrough-designation-china-autoimmune-hemolytic-anemia 2026-05-04T19:56:54.144Z monthly 0.6 https://novapharmanews.com/eu/news/fda-real-world-evidence-framework-medtech-ventripoint-10-billion 2026-05-04T17:11:02.764Z monthly 0.6 https://novapharmanews.com/us/news/teva-acquires-emalex-ecopipam-tourette-syndrome-drug-700-million 2026-05-04T19:45:55.360Z monthly 0.6 https://novapharmanews.com/us/news/purespring-therapeutics-nphs2-genetic-variants-adult-onset-fsgs-study 2026-05-04T12:50:25.732Z monthly 0.6 https://novapharmanews.com/us/news/viking-therapeutics-vk2735-phase-3-obesity-trials-enrolled-q1-2026 2026-05-04T04:18:30.504Z monthly 0.6 https://novapharmanews.com/us/news/relay-therapeutics-q1-2026-earnings-zovegalisib-updates-may-5 2026-05-04T22:09:44.172Z monthly 0.6 https://novapharmanews.com/us/news/neurocrine-ingrezza-tardive-dyskinesia-improvement-threshold-study 2026-05-04T19:48:38.842Z monthly 0.6 https://novapharmanews.com/us/news/novo-nordisk-denecimig-hemophilia-a-phase-3-trial-nejm 2026-05-03T21:25:29.611Z monthly 0.6 https://novapharmanews.com/us/news/addex-gabab-pam-ipf-chronic-cough-preclinical-results 2026-05-04T01:25:11.684Z monthly 0.6 https://novapharmanews.com/us/news/iga-nephropathy-market-forecast-2036-novartis-zigakibart-immunotherapies 2026-05-04T12:50:36.812Z monthly 0.6 https://novapharmanews.com/us/news/perimeter-medical-claire-oct-ai-fda-approval-breast-cancer-surgery 2026-05-04T12:50:18.885Z monthly 0.6 https://novapharmanews.com/us/news/regeneron-q1-2026-earnings-dupixent-eylea-hd-sales-growth 2026-05-04T12:50:37.091Z monthly 0.6 https://novapharmanews.com/us/news/sprout-pharmaceuticals-addyi-flibanserin-time-top-10-influential-health-companies-2026 2026-05-04T12:53:08.427Z monthly 0.6 https://novapharmanews.com/eu/news/biopharma-clinical-trials-eu-daily-insights 2026-05-04T01:45:02.533Z monthly 0.6 https://novapharmanews.com/us/news/clinical-outsourcing-2026-key-takeaways 2026-05-04T12:00:08.323Z monthly 0.6 https://novapharmanews.com/us/news/clinical-outsourcing-trends-2026-key-takeaways 2026-05-04T21:00:08.492Z monthly 0.6 https://novapharmanews.com/us/news/ieee-cog-2026-industry-day-game-dev-tutorials 2026-05-04T17:50:53.480Z monthly 0.6 https://novapharmanews.com/apac/news/chinabio-partnering-forum-2026-highlights 2026-05-03T23:16:29.300Z monthly 0.6 https://novapharmanews.com/us/news/pharma-partnering-us-biotech-dealmaking 2026-05-04T01:37:36.244Z monthly 0.6 https://novapharmanews.com/us/news/clinical-outsourcing-group-pharma-takeaways 2026-05-04T13:56:36.190Z monthly 0.6 https://novapharmanews.com/apac/news/chinabio-partnering-forum-biotech-deals-apac 2026-05-04T02:33:41.937Z monthly 0.6 https://novapharmanews.com/apac/news/insilico-rentosertib-inhalation-ind-clearance-ai-drug-clinical-trial 2026-05-04T22:32:56.509Z monthly 0.6 https://novapharmanews.com/apac/news/thailand-asean-medical-device-market-gateway-2029 2026-05-04T07:29:06.314Z monthly 0.6 https://novapharmanews.com/apac/news/yangtze-river-pharmaceutical-group-international-revenue-growth-2025 2026-05-04T22:33:10.006Z monthly 0.6 https://novapharmanews.com/apac/news/soleno-therapeutics-securities-fraud-lawsuit-phase-3-clinical-trials 2026-05-04T07:12:18.696Z monthly 0.6 https://novapharmanews.com/apac/news/newleos-ntx-2001-phase-1b-trial-alcohol-use-disorder 2026-05-04T04:03:46.805Z monthly 0.6 https://novapharmanews.com/apac/news/citius-oncology-lymphir-first-international-shipment-europe 2026-05-04T03:29:24.149Z monthly 0.6 https://novapharmanews.com/apac/news/eirgenix-japan-biosimilar-expansion-cphi-2026 2026-05-04T05:27:09.312Z monthly 0.6 https://novapharmanews.com/eu/news/european-commission-approves-poherdy-pertuzumab-biosimilar-henlius-organon 2026-05-04T12:54:12.896Z monthly 0.6 https://novapharmanews.com/eu/news/puretech-lyt-200-clinical-results-myeloid-malignancies-2025 2026-05-04T21:52:08.945Z monthly 0.6 https://novapharmanews.com/eu/news/enterobiotix-19m-funding-phase-2b-ibs-microbiome-trial 2026-05-04T19:01:36.543Z monthly 0.6 https://novapharmanews.com/eu/news/ray-therapeutics-rtx-015-ema-prime-designation-retinitis-pigmentosa 2026-05-04T12:54:10.368Z monthly 0.6 https://novapharmanews.com/eu/news/x4-pharmaceuticals-xolremdi-mavorixafor-european-approval-whim-syndrome 2026-05-04T19:22:00.912Z monthly 0.6 https://novapharmanews.com/eu/news/norgine-xolremdi-mavorixafor-whim-syndrome-european-approval 2026-05-04T19:35:35.261Z monthly 0.6 https://novapharmanews.com/eu/news/norgine-xolremdi-mavorixafor-european-approval-whim-syndrome-treatment 2026-05-04T20:59:08.325Z monthly 0.6 https://novapharmanews.com/eu/news/ema-expert-panel-covid-19-mrna-vaccine-trust-spikevax-comirnaty 2026-05-04T17:25:36.497Z monthly 0.6 https://novapharmanews.com/eu/news/henlius-organon-poherdy-first-pertuzumab-biosimilar-approved-europe 2026-05-04T22:34:45.922Z monthly 0.6 https://novapharmanews.com/us/news/fda-clinical-hold-newron-evenamide-phase-3-trial-treatment-resistant-schizophrenia 2026-05-03T22:11:22.815Z monthly 0.6 https://novapharmanews.com/us/news/teva-q1-2026-results-ponlimsi-fda-approval-olanzapine-lai 2026-05-04T12:50:33.783Z monthly 0.6 https://novapharmanews.com/us/news/teva-acquires-emalex-ecopipam-tourette-syndrome-drug 2026-05-04T21:20:44.035Z monthly 0.6 https://novapharmanews.com/us/news/teva-ponlimsi-biosimilar-fda-approval-prolia-q1-2026-results 2026-05-04T22:25:07.018Z monthly 0.6 https://novapharmanews.com/us/news/bayer-asundexian-stroke-trial-esoc-2026-abstracts 2026-05-04T12:53:08.520Z monthly 0.6 https://novapharmanews.com/us/news/tempest-therapeutics-tpst-2003-car-t-multiple-myeloma-isct-2026 2026-05-04T12:50:18.903Z monthly 0.6 https://novapharmanews.com/us/news/pfizer-elrexfio-progression-free-survival-multiple-myeloma-phase-3-trial 2026-05-04T12:50:19.231Z monthly 0.6 https://novapharmanews.com/us/news/rein-therapeutics-lti-03-phase-2-trial-enrollment-update-ipf 2026-05-04T03:44:01.176Z monthly 0.6 https://novapharmanews.com/us/news/laguna-biotherapeutics-fda-clearance-lgna-100-pediatric-leukemia-trial 2026-05-03T23:47:30.740Z monthly 0.6 https://novapharmanews.com/us/news/expression-therapeutics-fda-fast-track-hemophilia-a-stem-cell-therapy 2026-05-04T18:24:19.557Z monthly 0.6 https://novapharmanews.com/us/news/fda-priority-review-gilead-bictegravir-lenacapavir-hiv-treatment 2026-05-04T04:08:01.974Z monthly 0.6 https://novapharmanews.com/us/news/regeneron-otarmeni-gene-therapy-free-hearing-loss-government-agreement 2026-05-04T22:30:37.059Z monthly 0.6 https://novapharmanews.com/eu/news/eu-biopharma-clinical-trials-daily-roundup 2026-05-03T20:38:31.171Z monthly 0.6 https://novapharmanews.com/us/news/pharma-partnering-us-biotech-deals 2026-05-04T02:39:28.051Z monthly 0.6 https://novapharmanews.com/us/news/cog-2024-daily-highlights 2026-05-04T02:06:47.516Z monthly 0.6 https://novapharmanews.com/apac/news/chinabio-partnering-forum-biotech-deals-investment 2026-05-04T22:04:31.653Z monthly 0.6 https://novapharmanews.com/us/news/asco-2026-oncology-data-readouts 2026-05-04T12:51:55.623Z monthly 0.6 https://novapharmanews.com/us/news/asco-2026-oncology-trials-preview 2026-05-04T22:04:57.230Z monthly 0.6 https://novapharmanews.com/us/news/fda-redi-conference-2026-regulatory-strategies 2026-05-04T12:52:15.386Z monthly 0.6 https://novapharmanews.com/eu/news/eu-biopharma-clinical-trials-daily-insights 2026-05-04T01:31:36.429Z monthly 0.6 https://novapharmanews.com/us/news/pharma-partnering-us-biotech-deals-investment 2026-05-04T21:29:22.903Z monthly 0.6 https://novapharmanews.com/us/news/pharma-partnering-us-biotech-deals-day-1 2026-05-04T19:39:10.737Z monthly 0.6 https://novapharmanews.com/apac/news/trialcliniq-150k-investment-caduceus-capital-ai-clinical-trial-recruitment 2026-05-04T21:26:52.974Z monthly 0.6 https://novapharmanews.com/apac/news/argo-biopharma-bw-50218-phase-1-trial-first-patient-sirna-therapy 2026-05-04T22:33:14.013Z monthly 0.6 https://novapharmanews.com/apac/news/claruvis-retoxin-first-recombinant-botulinum-toxin-approval-china 2026-05-04T18:48:19.021Z monthly 0.6 https://novapharmanews.com/apac/news/jyong-biotech-botreso-botanical-drug-market-access-strategy-2026 2026-05-03T22:09:48.287Z monthly 0.6 https://novapharmanews.com/apac/news/arcera-life-sciences-fosun-pharma-neurodegenerative-disease-collaboration 2026-05-04T15:58:09.381Z monthly 0.6 https://novapharmanews.com/apac/news/samsung-bioepis-atlatl-partnership-asia-pacific-biotech-innovation 2026-05-02T11:40:07.274Z monthly 0.6 https://novapharmanews.com/apac/news/tga-implantable-medical-devices-regulatory-framework-australia-2024 2026-05-04T03:07:39.580Z monthly 0.6 https://novapharmanews.com/apac/news/immunic-appoints-michael-panzara-chief-medical-officer-vidofludimus-calcium 2026-05-04T20:17:35.409Z monthly 0.6 https://novapharmanews.com/apac/news/zhengye-biotechnology-fiscal-2025-financial-results-veterinary-vaccines 2026-05-04T22:22:29.565Z monthly 0.6 https://novapharmanews.com/eu/news/vivosim-labs-ai-tool-predicts-drug-diarrhea-without-animal-testing 2026-05-04T03:07:25.128Z monthly 0.6 https://novapharmanews.com/eu/news/boehringer-ingelheim-survodutide-weight-loss-phase-2-trial-results 2026-05-04T16:40:30.049Z monthly 0.6 https://novapharmanews.com/eu/news/idorsia-quviviq-74-percent-sales-growth-q1-2026-european-expansion 2026-05-04T20:30:23.703Z monthly 0.6 https://novapharmanews.com/eu/news/small-molecule-api-market-202-billion-2036-generic-drugs 2026-05-04T21:53:18.528Z monthly 0.6 https://novapharmanews.com/eu/news/silexion-therapeutics-sil204-phase-2-3-trial-kras-pancreatic-cancer 2026-05-04T19:50:52.098Z monthly 0.6 https://novapharmanews.com/eu/news/novo-nordisk-wegovy-data-women-obesity-european-congress-2026 2026-05-04T16:50:00.702Z monthly 0.6 https://novapharmanews.com/eu/news/solid-biosciences-sgt-003-european-orphan-drug-designation-duchenne-muscular-dystrophy 2026-05-04T12:54:10.404Z monthly 0.6 https://novapharmanews.com/eu/news/cytokinetics-myqorzo-aficamten-esc-heart-failure-2026-congress 2026-05-04T22:55:55.244Z monthly 0.6 https://novapharmanews.com/eu/news/artiva-biotherapeutics-allonk-fda-fast-track-rheumatoid-arthritis 2026-05-04T12:54:22.348Z monthly 0.6 https://novapharmanews.com/eu/news/sq-innovation-lasix-onyu-ce-marking-approval-european-market 2026-05-04T12:54:25.537Z monthly 0.6 https://novapharmanews.com/us/news/aop-health-rapiblyk-landiolol-first-patient-treatment-us 2026-05-04T05:14:52.286Z monthly 0.6 https://novapharmanews.com/us/news/emergent-biosolutions-substipharm-japanese-encephalitis-vaccine-manufacturing-partnership 2026-05-03T20:33:12.992Z monthly 0.6 https://novapharmanews.com/us/news/cordis-selution-slr-drug-eluting-balloon-japan-launch 2026-05-04T18:32:24.432Z monthly 0.6 https://novapharmanews.com/us/news/zealand-pharma-survodutide-weight-loss-phase-3-trial-results 2026-05-04T21:35:46.401Z monthly 0.6 https://novapharmanews.com/us/news/ashvattha-therapeutics-migaldendranib-diabetic-macular-edema-amd-data 2026-05-04T21:51:19.729Z monthly 0.6 https://novapharmanews.com/us/news/aclaris-ati-052-phase-1a-trial-results-45-day-half-life 2026-05-04T13:05:19.250Z monthly 0.6 https://novapharmanews.com/us/news/trevi-therapeutics-q1-2026-earnings-haduvio-chronic-cough-updates 2026-05-04T21:51:44.789Z monthly 0.6 https://novapharmanews.com/us/news/soligenix-hybryte-phase-3-flash2-trial-interim-results-ctcl 2026-05-04T21:50:30.905Z monthly 0.6 https://novapharmanews.com/us/news/avicanna-us-cannabis-rescheduling-medical-research-development 2026-05-04T12:50:56.091Z monthly 0.6 https://novapharmanews.com/us/news/innocare-orelabrutinib-phase-3-trial-sle-treatment 2026-05-04T21:47:05.207Z monthly 0.6 https://novapharmanews.com/us/news/orca-bio-orca-q-fda-rmat-designation-blood-cancers 2026-05-03T10:50:17.631Z monthly 0.6 https://novapharmanews.com/us/news/formblends-2026-peptide-report-rfk-hhs-glp1-therapy-access 2026-05-04T22:52:24.214Z monthly 0.6 https://novapharmanews.com/us/news/c-ray-therapeutics-fda-copper-64-drug-master-file-approval 2026-05-04T17:50:56.282Z monthly 0.6 https://novapharmanews.com/us/news/brc-therapeutics-fda-clearance-brc-002-phase-1-trial-crps 2026-05-04T04:39:22.819Z monthly 0.6 https://novapharmanews.com/us/news/vanda-pharmaceuticals-imsidolimab-generalized-pustular-psoriasis-nejm-evidence 2026-05-04T18:31:56.630Z monthly 0.6 https://novapharmanews.com/us/news/astrazeneca-breztri-aerosphere-approved-first-triple-therapy-asthma-patients-12-older 2026-05-04T22:59:25.732Z monthly 0.6 https://novapharmanews.com/us/news/vensica-medical-fda-ind-approval-vixe-xeomin-needle-free-delivery-overactive-bladder 2026-05-04T19:54:30.698Z monthly 0.6 https://novapharmanews.com/us/news/abbvie-upadacitinib-rinvoq-fda-application-alopecia-areata 2026-05-03T17:15:53.041Z monthly 0.6 https://novapharmanews.com/us/news/novartis-q1-2026-earnings-remibrutinib-chmp-approval-pipeline-growth 2026-05-04T21:18:56.840Z monthly 0.6 https://novapharmanews.com/us/news/wave-life-sciences-wve-007-phase-2a-fda-approval-obesity-diabetes 2026-05-04T12:50:30.345Z monthly 0.6 https://novapharmanews.com/eu/news/biopharma-clinical-trials-daily-roundup 2026-05-04T13:00:38.545Z monthly 0.6 https://novapharmanews.com/us/news/pharma-partnering-us-emergent-evolveimmune-deals 2026-05-04T02:54:25.802Z monthly 0.6 https://novapharmanews.com/us/news/pharma-partnering-us-deal-surge-lilly-sun 2026-05-04T19:01:49.685Z monthly 0.6 https://novapharmanews.com/apac/news/chinabio-partnering-forum-biotech-investment-trends 2026-05-03T23:45:47.053Z monthly 0.6 https://novapharmanews.com/us/news/pharma-compliance-congress-annex-1-challenges 2026-05-04T21:06:44.296Z monthly 0.6 https://novapharmanews.com/us/news/cog-2024-day-1-highlights 2026-05-04T00:33:15.339Z monthly 0.6 https://novapharmanews.com/us/news/clinical-outsourcing-group-event-day-1 2026-05-04T22:44:54.013Z monthly 0.6 https://novapharmanews.com/us/news/clinical-outsourcing-group-daily-roundup 2026-05-04T22:44:52.024Z monthly 0.6 https://novapharmanews.com/us/news/ascrs-2026-opus-genetics-phentolamine-preview 2026-05-04T03:35:25.876Z monthly 0.6 https://novapharmanews.com/us/news/fdli-2026-fda-strategic-priorities 2026-05-04T01:06:01.472Z monthly 0.6 https://novapharmanews.com/us/news/cog-2024-day-1-roundup 2026-05-03T20:07:05.166Z monthly 0.6 https://novapharmanews.com/us/news/clinical-outsourcing-group-2026-daily-roundup 2026-05-04T06:39:09.789Z monthly 0.6 https://novapharmanews.com/apac/news/akso-health-group-brain-computer-interface-rd-program-neurotechnology 2026-05-04T16:15:29.706Z monthly 0.6 https://novapharmanews.com/apac/news/evofem-solosec-distribution-agreement-sub-saharan-africa 2026-05-04T17:15:51.056Z monthly 0.6 https://novapharmanews.com/apac/news/psg-2026-specialty-drug-benefits-report-cost-management-coverage-strategies 2026-05-04T06:45:01.266Z monthly 0.6 https://novapharmanews.com/apac/news/wuxi-apptec-q1-2026-revenue-growth-backlog-results 2026-05-03T20:30:41.169Z monthly 0.6 https://novapharmanews.com/apac/news/img-pharma-acquires-matsumoto-pharmaceutical-japan-expansion 2026-05-04T12:52:41.876Z monthly 0.6 https://novapharmanews.com/apac/news/aquestive-therapeutics-anaphylm-class-action-lawsuit-approval-timeline 2026-05-04T22:33:34.023Z monthly 0.6 https://novapharmanews.com/apac/news/biomarin-completes-amicus-therapeutics-acquisition-galafold-pompe-therapies 2026-05-04T14:54:07.675Z monthly 0.6 https://novapharmanews.com/eu/news/elanco-negasunt-tanidil-emergency-authorization-screwworm-livestock 2026-05-04T14:24:36.745Z monthly 0.6 https://novapharmanews.com/eu/news/opella-essentiale-excel-trial-fatty-liver-disease-masld-results 2026-05-03T20:32:25.628Z monthly 0.6 https://novapharmanews.com/eu/news/advanced-bifurcation-systems-acquires-svelte-medical-coronary-stent-deal 2026-05-04T12:54:25.558Z monthly 0.6 https://novapharmanews.com/eu/news/zentiva-appeals-eu-court-urban-wastewater-directive-generic-medicines 2026-05-04T12:54:31.589Z monthly 0.6 https://novapharmanews.com/eu/news/ab-science-loan-repayment-deferral-agreement-2026 2026-05-03T23:41:58.685Z monthly 0.6 https://novapharmanews.com/eu/news/mundipharma-rezzayo-rezafungin-phase-iii-respect-trial-results-fungal-disease-prevention 2026-05-04T17:03:16.472Z monthly 0.6 https://novapharmanews.com/eu/news/crinetics-palsonify-paltusotine-eu-approval-acromegaly-treatment 2026-05-04T12:54:20.244Z monthly 0.6 https://novapharmanews.com/us/news/cellenkos-fda-clearance-ck0801-phase-2-aplastic-anemia-trial 2026-05-04T19:49:07.775Z monthly 0.6 https://novapharmanews.com/us/news/astrazeneca-saphnelo-autoinjector-fda-approved-lupus-self-administration 2026-05-03T21:12:48.932Z monthly 0.6 https://novapharmanews.com/us/news/dmx-200-action3-trial-statistical-power-blinded-review 2026-05-04T04:19:06.090Z monthly 0.6 https://novapharmanews.com/us/news/concept-medical-sirona-trial-3-year-data-charing-cross-2026 2026-05-04T12:50:53.679Z monthly 0.6 https://novapharmanews.com/us/news/intellia-lonvo-z-fda-submission-crispr-hereditary-angioedema 2026-05-04T19:53:55.265Z monthly 0.6 https://novapharmanews.com/us/news/cordis-selution-slr-drug-eluting-balloon-japan-launch-2026 2026-05-04T19:50:28.737Z monthly 0.6 https://novapharmanews.com/us/news/tovecimig-biliary-tract-cancer-trial-results-companion-002 2026-05-04T07:05:00.495Z monthly 0.6 https://novapharmanews.com/us/news/intellia-lonvoguran-ziclumeran-phase-3-hereditary-angioedema-gene-editing 2026-05-04T22:19:11.780Z monthly 0.6 https://novapharmanews.com/us/news/sagimet-biosciences-denifanstat-phase-3-acne-trial-2026 2026-05-04T07:06:03.770Z monthly 0.6 https://novapharmanews.com/us/news/apollomics-vebreltinib-phase-2-3-ind-submission-nsclc-treatment 2026-05-03T21:14:38.388Z monthly 0.6 https://novapharmanews.com/us/news/aclaris-therapeutics-ati-052-phase-1a-results-ati-2138-update-april-2026 2026-05-04T00:13:35.174Z monthly 0.6 https://novapharmanews.com/us/news/ose-immunotherapeutics-pegrizeprument-vel-101-fda-orphan-drug-designation-heart-transplant 2026-05-04T04:09:09.362Z monthly 0.6 https://novapharmanews.com/us/news/jazz-pharmaceuticals-ziihera-fda-priority-review-her2-cancer 2026-05-03T19:09:57.983Z monthly 0.6 https://novapharmanews.com/us/news/nccn-adds-nuvation-bio-taletrectinib-ibtrozi-cancer-guidelines-ros1-nsclc-brain-metastases 2026-05-04T08:50:47.048Z monthly 0.6 https://novapharmanews.com/us/news/fda-priority-review-imaavy-nipocalimab-warm-autoimmune-hemolytic-anemia 2026-05-04T03:35:12.696Z monthly 0.6 https://novapharmanews.com/us/news/fda-approves-caplyta-lumateperone-snda-schizophrenia-relapse-prevention 2026-05-03T21:28:05.239Z monthly 0.6 https://novapharmanews.com/us/news/apotex-fda-approval-generic-infuvite-pediatric-injection-exclusivity 2026-05-03T21:51:03.112Z monthly 0.6 https://novapharmanews.com/us/news/clinical-outsourcing-group-pharma-news-roundup-april-28-2026 2026-05-04T22:46:57.854Z monthly 0.6 https://novapharmanews.com/us/news/4th-annual-cog-2026-no-pharma-news 2026-05-04T05:40:45.877Z monthly 0.6 https://novapharmanews.com/us/news/pharma-compliance-congress-day-1-roundup 2026-05-04T12:53:15.566Z monthly 0.6 https://novapharmanews.com/us/news/acrp-2026-patient-centric-trials-workforce 2026-05-03T22:44:06.164Z monthly 0.6 https://novapharmanews.com/us/news/pharma-compliance-congress-regulatory-updates-day-1 2026-05-04T19:54:44.726Z monthly 0.6 https://novapharmanews.com/us/news/testosterone-therapy-fda-update-regulatory-advances 2026-05-04T12:52:16.995Z monthly 0.6 https://novapharmanews.com/us/news/glp-1-eating-disorder-risk-true-facts 2026-05-04T22:28:52.634Z monthly 0.6 https://novapharmanews.com/us/news/aacr-2026-ai-pathology-oncolytic-virus 2026-05-04T12:52:25.920Z monthly 0.6 https://novapharmanews.com/us/news/interphex-2026-phillips-medisize-sensing 2026-05-04T13:39:11.241Z monthly 0.6 https://novapharmanews.com/eu/news/reuters-pharma-ai-patient-centricity 2026-05-03T10:03:04.776Z monthly 0.6 https://novapharmanews.com/eu/news/pharma-2026-eu-biopharma-medtech-highlights 2026-05-04T00:26:42.707Z monthly 0.6 https://novapharmanews.com/eu/news/reuters-pharma-eu-funding-dealmaking-highlights 2026-05-03T18:31:13.287Z monthly 0.6 https://novapharmanews.com/eu/news/asco-2026-olverembatinib-gastric-cancer-trials 2026-05-03T07:18:08.436Z monthly 0.6 https://novapharmanews.com/eu/news/pharma-sustainability-2026-packaging-preview 2026-05-04T05:41:01.009Z monthly 0.6 https://novapharmanews.com/us/news/pharma-compliance-congress-day-1-regulatory-updates 2026-05-04T12:52:15.597Z monthly 0.6 https://novapharmanews.com/apac/news/eyebright-medical-2025-annual-report-sustainability-results 2026-05-04T18:30:12.967Z monthly 0.6 https://novapharmanews.com/apac/news/pmda-japanese-pharmacopoeia-medical-device-standards-regulatory-science 2026-05-04T21:08:21.515Z monthly 0.6 https://novapharmanews.com/eu/news/boston-scientific-securities-class-action-lawsuit-may-2026 2026-05-04T12:54:25.534Z monthly 0.6 https://novapharmanews.com/eu/news/brii-bio-elebsiran-hepatitis-b-control-apasl-2026-analysis 2026-05-04T18:13:47.733Z monthly 0.6 https://novapharmanews.com/us/news/ascletis-asc30-oral-glp-1-diabetes-phase-2-trial-enrollment-complete 2026-05-04T13:58:07.277Z monthly 0.6 https://novapharmanews.com/us/news/ascletis-asc30-phase-ii-enrollment-complete-oral-glp1-diabetes 2026-05-02T22:47:53.984Z monthly 0.6 https://novapharmanews.com/us/news/sun-pharma-acquires-organon-11-75-billion-merger-2026 2026-05-04T21:47:08.017Z monthly 0.6 https://novapharmanews.com/us/news/boston-scientific-farapulse-watchman-heart-rhythm-2026-data 2026-05-04T20:09:56.950Z monthly 0.6 https://novapharmanews.com/us/news/veradermics-vdphl01-phase-2-3-trial-results-male-pattern-hair-loss 2026-05-03T09:53:35.511Z monthly 0.6 https://novapharmanews.com/us/news/veradermics-vdphl01-phase-2-3-trial-results-conference-call 2026-05-04T21:36:21.482Z monthly 0.6 https://novapharmanews.com/us/news/adagio-medical-vclas-ventricular-ablation-system-pivotal-trial-results 2026-05-04T18:24:05.447Z monthly 0.6 https://novapharmanews.com/us/news/pharma-compliance-congress-2026-opens 2026-05-04T12:52:15.870Z monthly 0.6 https://novapharmanews.com/us/news/acrp-2026-immunology-daily-roundup 2026-05-04T12:52:07.110Z monthly 0.6 https://novapharmanews.com/apac/news/pmc-organometallix-price-increase-all-products-may-2026 2026-05-04T22:54:00.306Z monthly 0.6 https://novapharmanews.com/apac/news/tga-personalised-medical-device-regulations-guidance-2024 2026-05-04T17:03:41.533Z monthly 0.6 https://novapharmanews.com/us/news/atara-biotherapeutics-securities-class-action-lawsuit-may-2026-deadline 2026-05-04T11:01:00.597Z monthly 0.6 https://novapharmanews.com/us/news/aquestive-therapeutics-class-action-lawsuit-fda-application 2026-05-04T15:33:15.258Z monthly 0.6 https://novapharmanews.com/us/news/pulse-biosciences-npulse-cardiac-catheter-heart-rhythm-2026-trial-data 2026-05-04T19:48:14.320Z monthly 0.6 https://novapharmanews.com/us/news/abbott-tactiflex-duo-ablation-catheter-afib-results-hrs-2026 2026-05-04T18:30:02.501Z monthly 0.6 https://novapharmanews.com/us/news/medtronic-affera-sphere-9-catheter-fda-breakthrough-device-designation-ventricular-tachycardia 2026-05-04T19:50:09.028Z monthly 0.6 https://novapharmanews.com/eu/news/ema-positive-opinion-rexatilux-ranibizumab-eye-treatment 2026-05-04T12:54:29.292Z monthly 0.6 https://novapharmanews.com/eu/news/ema-positive-opinion-redemplo-plozasiran-european-approval 2026-05-04T12:49:41.945Z monthly 0.6 https://novapharmanews.com/eu/news/ema-positive-opinion-viatris-palbociclib-generic-cancer-treatment 2026-05-04T20:12:33.601Z monthly 0.6 https://novapharmanews.com/eu/news/ema-positive-opinion-itvisma-onasemnogene-abeparvovec-sma-gene-therapy 2026-05-04T19:48:28.456Z monthly 0.6 https://novapharmanews.com/eu/news/ema-positive-opinion-cenrifki-tolebrutinib-multiple-sclerosis 2026-05-04T12:59:17.279Z monthly 0.6 https://novapharmanews.com/eu/news/ema-approves-first-rna-veterinary-vaccine-nobivac-nxt-cats 2026-05-04T03:57:24.672Z monthly 0.6 https://novapharmanews.com/eu/news/ema-approves-plozasiran-redemplo-familial-chylomicronaemia-syndrome-fcs 2026-05-04T12:54:20.953Z monthly 0.6 https://novapharmanews.com/eu/news/ema-chmp-recommends-tolebrutinib-cenrifki-five-medicines-approval-april-2026 2026-05-04T12:54:15.220Z monthly 0.6 https://novapharmanews.com/us/news/fda-gdufa-generic-drug-user-fee-amendments-2024-updates 2026-05-04T12:50:57.008Z monthly 0.6 https://novapharmanews.com/us/news/fda-omufa-user-fee-program-otc-monograph-drugs 2026-05-04T12:50:57.208Z monthly 0.6 https://novapharmanews.com/us/news/fda-gdufa-iv-reauthorization-2028-2032-generic-drug-user-fees 2026-05-04T12:50:57.242Z monthly 0.6 https://novapharmanews.com/us/news/fda-testosterone-therapy-low-libido-hypogonadism-2024 2026-05-04T12:50:57.776Z monthly 0.6 https://novapharmanews.com/us/news/fda-reduces-animal-testing-drug-development-alternatives-2024 2026-05-04T12:50:57.776Z monthly 0.6 https://novapharmanews.com/us/news/cms-fda-rapid-coverage-pathway-breakthrough-medical-devices-medicare 2026-05-04T12:50:57.849Z monthly 0.6 https://novapharmanews.com/us/news/fda-approves-otarmeni-first-gene-therapy-genetic-hearing-loss 2026-05-04T18:29:23.306Z monthly 0.6 https://novapharmanews.com/us/news/fda-accelerates-mental-health-treatment-access-executive-order 2026-05-04T21:09:50.196Z monthly 0.6 https://novapharmanews.com/us/news/acrp-2026-immunology-day-1-roundup 2026-05-02T12:52:26.940Z monthly 0.6 https://novapharmanews.com/us/news/scope-x-2026-clinical-ops-data-ai-boston 2026-05-02T12:03:10.671Z monthly 0.6 https://novapharmanews.com/us/news/oct-east-coast-2026-clinical-trial-innovation 2026-05-04T12:52:07.167Z monthly 0.6 https://novapharmanews.com/apac/news/sunnybrook-41-million-investment-clinical-trials-canada 2026-05-04T02:10:42.642Z monthly 0.6 https://novapharmanews.com/apac/news/wuxi-biologics-chengdu-microbial-manufacturing-completion-2026 2026-05-02T04:41:40.351Z monthly 0.6 https://novapharmanews.com/apac/news/quasar-medical-thailand-manufacturing-facility-medtech-expansion 2026-05-04T11:07:12.601Z monthly 0.6 https://novapharmanews.com/apac/news/daewoong-nabota-master-class-prabotulinumtoxina-safety-2026 2026-05-04T22:34:53.928Z monthly 0.6 https://novapharmanews.com/apac/news/amcor-35m-healthcare-packaging-facility-malaysia-medical-supply-chain 2026-05-04T09:44:34.352Z monthly 0.6 https://novapharmanews.com/apac/news/transcarent-smithrx-partnership-pharmacy-benefits-platform 2026-05-04T15:50:13.413Z monthly 0.6 https://novapharmanews.com/apac/news/hanchorbio-bloomberg-partnership-drug-development-intelligence 2026-05-04T22:05:01.892Z monthly 0.6 https://novapharmanews.com/eu/news/aetna-prior-authorization-reform-88-percent-standardized-2026 2026-05-03T06:25:42.663Z monthly 0.6 https://novapharmanews.com/eu/news/guerbet-lipiodol-ultra-fluid-eu-approval-vascular-embolization 2026-05-04T20:11:03.830Z monthly 0.6 https://novapharmanews.com/eu/news/rna-therapy-clinical-trials-market-3-4-billion-2035-forecast 2026-05-04T12:54:33.519Z monthly 0.6 https://novapharmanews.com/eu/news/oncotelic-therapeutics-partnership-strategy-update-2026 2026-05-03T21:08:27.084Z monthly 0.6 https://novapharmanews.com/eu/news/clinuvel-scenesse-phase-iii-vitiligo-trial-ema-approval-2026 2026-05-03T06:29:05.519Z monthly 0.6 https://novapharmanews.com/us/news/frankfurt-court-upholds-besremi-arbitral-award-aop-health-pharmaessentia 2026-05-03T07:33:36.699Z monthly 0.6 https://novapharmanews.com/us/news/novartis-coartem-baby-who-prequalification-malaria-treatment-newborns 2026-05-03T14:58:05.877Z monthly 0.6 https://novapharmanews.com/us/news/miracell-smart-m-cell-alzheimers-stem-cell-therapy-results 2026-05-04T20:44:33.693Z monthly 0.6 https://novapharmanews.com/us/news/berlin-heals-positive-cmic-iii-heart-failure-device-results 2026-05-04T09:29:28.385Z monthly 0.6 https://novapharmanews.com/us/news/citius-pharmaceuticals-5-million-direct-offering-stock-nasdaq 2026-05-03T04:24:48.473Z monthly 0.6 https://novapharmanews.com/us/news/haemonetics-vascade-mvp-xl-safety-efficacy-study-large-bore-venous-closure 2026-05-02T22:21:53.764Z monthly 0.6 https://novapharmanews.com/us/news/briohealth-solutions-fda-approval-pediatric-briovad-heart-device-trial 2026-05-03T09:13:42.541Z monthly 0.6 https://novapharmanews.com/us/news/cgbio-fda-clearance-easymade-ti-titanium-implant 2026-05-03T20:47:14.734Z monthly 0.6 https://novapharmanews.com/us/news/cerapedics-vizient-supplier-agreement-pearlmatrix-p15-bone-graft 2026-05-04T16:55:33.321Z monthly 0.6 https://novapharmanews.com/us/news/acrp-2026-immunology-clinical-research-day-1 2026-05-03T10:30:25.340Z monthly 0.6 https://novapharmanews.com/us/news/acrp-2026-immunology-clinical-research-daily-roundup 2026-05-04T02:37:26.438Z monthly 0.6 https://novapharmanews.com/us/news/acrp-2026-immunology-clinical-research-trends 2026-05-04T19:35:55.999Z monthly 0.6 https://novapharmanews.com/apac/news/catalym-visugromab-phase-2-3-trial-cancer-cachexia-first-patient-dosed 2026-05-04T21:50:09.487Z monthly 0.6 https://novapharmanews.com/apac/news/spinogenix-spg601-clarity-trial-fragile-x-syndrome-phase-2b-3 2026-05-04T22:09:39.528Z monthly 0.6 https://novapharmanews.com/apac/news/tga-biologicals-regulatory-framework-advanced-therapies-australia 2026-05-04T10:01:42.656Z monthly 0.6 https://novapharmanews.com/eu/news/renovorx-tamp-therapy-asco-2026-tiger-pac-trial-data 2026-05-04T19:51:38.978Z monthly 0.6 https://novapharmanews.com/eu/news/genomics-services-market-24-billion-2033-precision-medicine 2026-05-03T06:33:45.265Z monthly 0.6 https://novapharmanews.com/eu/news/accenture-invests-iridius-ai-compliance-life-sciences 2026-05-04T11:57:42.534Z monthly 0.6 https://novapharmanews.com/eu/news/pharmaceutical-q1-2026-sales-growth-momentum 2026-05-04T22:57:20.747Z monthly 0.6 https://novapharmanews.com/eu/news/cumberland-pharmaceuticals-apotex-strategic-integration-partnership 2026-05-04T06:21:54.780Z monthly 0.6 https://novapharmanews.com/us/news/cortec-brain-interchange-bci-fda-tap-program-stroke-rehabilitation 2026-05-04T19:24:56.403Z monthly 0.6 https://novapharmanews.com/us/news/tivic-health-rebrands-valion-bio-entolimod-acute-radiation-syndrome-fda-fast-track 2026-05-04T12:50:58.392Z monthly 0.6 https://novapharmanews.com/us/news/edwards-lifesciences-q1-2026-results-tmtt-sales-guidance-raise 2026-05-04T21:09:26.107Z monthly 0.6 https://novapharmanews.com/us/news/immunitybio-ibrx-fda-warning-letter-class-action-lawsuit-anktiva 2026-05-04T21:18:21.654Z monthly 0.6 https://novapharmanews.com/us/news/transmedics-chops-organ-preservation-system-ishlt-2026 2026-05-03T17:15:28.900Z monthly 0.6 https://novapharmanews.com/us/news/abbvie-fda-complete-response-letter-trenibotulinumtoxine-trenibote-manufacturing 2026-05-04T06:12:44.777Z monthly 0.6 https://novapharmanews.com/us/news/alpha-tau-fda-approval-alpha-dart-pancreatic-cancer-trial-expansion 2026-05-03T03:49:44.407Z monthly 0.6 https://novapharmanews.com/us/news/fda-approves-regeneron-otarmeni-gene-therapy-genetic-hearing-loss 2026-05-04T22:25:01.421Z monthly 0.6 https://novapharmanews.com/us/news/acrp-2026-immunology-parexel-hiring 2026-05-02T04:03:52.091Z monthly 0.6 https://novapharmanews.com/eu/news/reuters-pharma-eu-day1-roundup 2026-05-04T03:51:50.560Z monthly 0.6 https://novapharmanews.com/us/news/generic-drug-forum-2026-highlights 2026-05-04T21:00:40.700Z monthly 0.6 https://novapharmanews.com/eu/news/tilray-brands-us-medical-cannabis-expansion-rescheduling-2026 2026-05-04T01:07:19.645Z monthly 0.6 https://novapharmanews.com/us/news/capricor-therapeutics-hope-3-phase-3-deramiocel-duchenne-muscular-dystrophy-aan-2026 2026-05-04T06:29:43.359Z monthly 0.6 https://novapharmanews.com/us/news/ctoc-a-new-paradigm-in-precision-nutrition-and-health-data-fbd60908 2026-05-03T17:43:27.563Z monthly 0.6 https://novapharmanews.com/us/news/a-secure-and-intelligent-drug-delivery-model-integrating-neural-networks-with-bl-853eecb6 2026-05-04T13:07:49.967Z monthly 0.6 https://novapharmanews.com/us/news/strengths-and-limitations-of-real-world-data-from-electronic-health-records-and-92ed37a9 2026-05-01T01:44:10.274Z monthly 0.6 https://novapharmanews.com/us/news/the-gross-to-net-squeeze-how-physician-led-patient-education-reduces-gtn-erosion-17169d71 2026-05-04T05:28:38.162Z monthly 0.6 https://novapharmanews.com/us/news/the-market-for-monoclonal-antibodies-trends-challenges-and-opportunities-7a342d06 2026-05-04T03:59:25.297Z monthly 0.6 https://novapharmanews.com/us/news/bbsw-ai-solution-event-pharma-ai-future 2026-05-04T06:18:40.791Z monthly 0.6 https://novapharmanews.com/us/news/formycon-ag-geschaftsbericht-2025-5ff7fa30 2026-05-04T22:15:24.366Z monthly 0.6 https://novapharmanews.com/apac/news/estado-actual-y-acciones-para-impulsar-la-investigacion-clinica-en-mexico-2025-5b7db092 2026-05-04T21:56:51.478Z monthly 0.6 https://novapharmanews.com/apac/news/samsung-bioepis-sbe303-phase-1-trial-sandoz-partnership-2026 2026-05-04T05:14:56.836Z monthly 0.6 https://novapharmanews.com/apac/news/fosun-health-wins-awards-globalhealth-asia-pacific-forum-2026 2026-05-04T00:42:05.489Z monthly 0.6 https://novapharmanews.com/apac/news/minjuvi-tafasitamab-approved-australia-follicular-lymphoma 2026-05-04T03:55:06.957Z monthly 0.6 https://novapharmanews.com/eu/news/ccbd-car-t-cell-therapy-maryland-community-oncology 2026-05-04T18:31:30.174Z monthly 0.6 https://novapharmanews.com/eu/news/samacare-prior-authorization-benchmarks-medical-benefit-drugs 2026-05-04T00:50:00.484Z monthly 0.6 https://novapharmanews.com/eu/news/repertoire-immune-medicines-rptr-1-201-phase-1-2-trial-advanced-solid-tumors 2026-05-04T12:54:22.572Z monthly 0.6 https://novapharmanews.com/eu/news/alpha-tau-alpha-dart-pancreatic-cancer-acapella-trial-first-patient 2026-05-04T21:51:31.816Z monthly 0.6 https://novapharmanews.com/eu/news/alpha-tau-alpha-dart-pancreatic-cancer-acapella-trial-europe 2026-05-04T11:53:05.247Z monthly 0.6 https://novapharmanews.com/eu/news/blinatumomab-pediatric-leukemia-safety-study-final-stage 2026-05-03T22:59:32.158Z monthly 0.6 https://novapharmanews.com/eu/news/healthcare-third-party-logistics-market-growth-502-billion-2034 2026-05-04T21:41:25.986Z monthly 0.6 https://novapharmanews.com/eu/news/pharmaceutical-intermediates-market-57-billion-2035-generic-drugs 2026-05-03T02:09:44.783Z monthly 0.6 https://novapharmanews.com/us/news/dupixent-approved-pediatric-chronic-spontaneous-urticaria-sanofi-regeneron 2026-05-04T00:26:47.374Z monthly 0.6 https://novapharmanews.com/us/news/ose-immunotherapeutics-tedopi-ovarian-cancer-asco-2026-presentation 2026-05-04T02:22:44.209Z monthly 0.6 https://novapharmanews.com/us/news/nectero-therapeutics-east-system-two-year-safety-data-abdominal-aortic-aneurysm 2026-05-03T20:50:54.365Z monthly 0.6 https://novapharmanews.com/us/news/novo-nordisk-oral-semaglutide-children-type-2-diabetes-pioneer-teens-trial 2026-05-03T23:03:35.192Z monthly 0.6 https://novapharmanews.com/us/news/neurosterix-ntx-253-schizophrenia-phase-1-trial-q2-2026 2026-05-04T02:54:00.779Z monthly 0.6 https://novapharmanews.com/us/news/greenwich-lifesciences-glsi-100-asco-2026-breast-cancer-immunotherapy 2026-05-04T21:04:16.860Z monthly 0.6 https://novapharmanews.com/us/news/mabwell-9mw2821-nectin-4-adc-phase-iii-triple-negative-breast-cancer 2026-05-04T04:28:36.049Z monthly 0.6 https://novapharmanews.com/us/news/clearpoint-neuro-fda-clearance-velocity-alpha-surgical-drill-system 2026-05-02T23:26:51.178Z monthly 0.6 https://novapharmanews.com/us/news/vistagen-refisolone-fda-approval-menopause-hot-flashes-phase-2-trial 2026-05-04T02:09:11.408Z monthly 0.6 https://novapharmanews.com/us/news/avai-bio-fda-cellular-rejuvenation-trial-anti-aging-market-120-billion 2026-05-04T06:26:50.432Z monthly 0.6 https://novapharmanews.com/us/news/cipla-fda-approval-first-generic-ventolin-hfa-albuterol-sulfate 2026-05-04T04:38:41.385Z monthly 0.6 https://novapharmanews.com/us/news/dupixent-approved-chronic-spontaneous-urticaria-children-sanofi 2026-05-04T16:05:51.193Z monthly 0.6 https://novapharmanews.com/us/news/oncology-data-trends-2026-preview 2026-05-04T12:51:55.910Z monthly 0.6 https://novapharmanews.com/us/news/redi-2026-fda-regulatory-strategies-conference-preview 2026-05-04T12:52:16.999Z monthly 0.6 https://novapharmanews.com/us/news/bionj-biopartnering-conference-2026-preview 2026-05-04T07:18:39.580Z monthly 0.6 https://novapharmanews.com/us/news/fierce-biotech-week-2026-boston-preview 2026-04-30T19:38:56.480Z monthly 0.6 https://novapharmanews.com/eu/news/reuters-pharma-day-1-eu-takeaways 2026-05-04T13:50:25.487Z monthly 0.6 https://novapharmanews.com/us/news/biomed-israel-2026-ai-biotech-preview 2026-05-04T22:18:50.965Z monthly 0.6 https://novapharmanews.com/eu/news/reuters-pharma-eu-day-1-roundup 2026-05-04T14:36:49.400Z monthly 0.6 https://novapharmanews.com/us/news/oct-east-coast-2026-cro-trends-outsourcing 2026-05-03T22:07:53.893Z monthly 0.6 https://novapharmanews.com/us/news/interphex-2026-biotech-day-1-roundup 2026-05-04T02:37:28.538Z monthly 0.6 https://novapharmanews.com/apac/news/calluna-pharma-cal101-phase-2-enrollment-ipf-treatment 2026-05-04T10:01:22.523Z monthly 0.6 https://novapharmanews.com/apac/news/anixa-biosciences-lira-cel-car-t-ovarian-cancer-survival-data 2026-05-04T22:34:47.923Z monthly 0.6 https://novapharmanews.com/apac/news/hengrui-pharma-q1-2026-anti-pd-l1-tgf-beta-fusion-protein-approved-china 2026-05-03T17:45:00.542Z monthly 0.6 https://novapharmanews.com/apac/news/sonorous-neurovascular-fda-clearance-boscath-catheter-2026 2026-05-03T22:14:12.094Z monthly 0.6 https://novapharmanews.com/apac/news/alphamab-oncology-jskn016-trop2-her3-bispecific-adc-her2-negative-breast-cancer-asco-2026 2026-05-03T22:20:45.710Z monthly 0.6 https://novapharmanews.com/apac/news/rfid-technology-pharmaceutical-supply-chain-15-billion-2032 2026-05-03T21:12:59.868Z monthly 0.6 https://novapharmanews.com/apac/news/wuxi-biologics-south-korea-gmp-certification-bispecific-antibody-manufacturing 2026-05-04T22:33:02.017Z monthly 0.6 https://novapharmanews.com/apac/news/australia-tga-therapeutic-sunscreen-regulatory-framework-2024 2026-05-04T22:33:52.040Z monthly 0.6 https://novapharmanews.com/eu/news/belite-bio-tinlarebant-nda-submission-stargardt-disease-phase-3-dragon-trial 2026-05-04T04:38:21.293Z monthly 0.6 https://novapharmanews.com/eu/news/abivax-obefazimod-phase-3-data-digestive-disease-week-2026 2026-05-04T12:54:22.816Z monthly 0.6 https://novapharmanews.com/eu/news/pet-service-holding-2025-annual-results-veterinary-regulatory-changes 2026-05-04T18:32:52.734Z monthly 0.6 https://novapharmanews.com/eu/news/femasys-femaseed-complete-fertility-solution-obgyn-acog-2026 2026-05-04T12:54:25.573Z monthly 0.6 https://novapharmanews.com/eu/news/mauna-kea-technologies-ce-mark-mdr-approval-european-expansion 2026-05-04T12:54:25.779Z monthly 0.6 https://novapharmanews.com/eu/news/pembrolizumab-lenvatinib-clear-cell-cancer-trial-results 2026-05-03T20:15:08.328Z monthly 0.6 https://novapharmanews.com/eu/news/roche-gazyva-fda-acceptance-lupus-treatment-phase-iii-allegory 2026-05-04T12:54:22.846Z monthly 0.6 https://novapharmanews.com/eu/news/dupixent-first-biologic-approved-chronic-spontaneous-urticaria-children 2026-05-04T12:54:23.239Z monthly 0.6 https://novapharmanews.com/eu/news/ipsen-ojemda-tovorafenib-eu-approval-pediatric-brain-cancer-braf 2026-05-04T06:39:02.698Z monthly 0.6 https://novapharmanews.com/us/news/alterity-ath434-multiple-system-atrophy-phase-2-results 2026-05-04T03:00:55.153Z monthly 0.6 https://novapharmanews.com/us/news/tempest-therapeutics-tpst-2003-car-t-manufacturing-milestone-2026 2026-05-04T20:48:45.433Z monthly 0.6 https://novapharmanews.com/us/news/phanes-therapeutics-spevatamig-phase-2-results-pancreatic-cancer-asco-2026 2026-05-04T17:24:19.759Z monthly 0.6 https://novapharmanews.com/us/news/netris-pharma-np137-pancreatic-cancer-phase-1b-nature-results 2026-05-04T15:40:16.078Z monthly 0.6 https://novapharmanews.com/us/news/neurosterix-ntx-253-phase-1-schizophrenia-trial-q2-2026 2026-05-04T04:13:58.703Z monthly 0.6 https://novapharmanews.com/us/news/mabwell-9mw2821-toripalimab-asco-2026-urothelial-carcinoma 2026-05-04T18:07:10.196Z monthly 0.6 https://novapharmanews.com/us/news/fda-complete-response-letter-atara-biotherapeutics-ebvallo-tabelecleucel-securities-lawsuit 2026-05-04T21:17:50.032Z monthly 0.6 https://novapharmanews.com/us/news/immunitybio-ibrx-securities-lawsuit-fda-warning-letter-cancer-claims 2026-05-04T02:31:35.266Z monthly 0.6 https://novapharmanews.com/us/news/nrx-pharmaceuticals-fda-positive-feedback-preservative-free-ketamine-generic 2026-05-04T01:10:04.970Z monthly 0.6 https://novapharmanews.com/us/news/labcorp-fda-approved-pd-l1-companion-diagnostic-keytruda-ovarian-cancer 2026-05-04T07:10:43.293Z monthly 0.6 https://novapharmanews.com/us/news/veloxis-pegrizeprument-fda-orphan-drug-designation-heart-transplant 2026-05-04T22:25:39.823Z monthly 0.6 https://novapharmanews.com/us/news/dupixent-approved-children-chronic-spontaneous-urticaria-csu 2026-05-04T20:50:25.916Z monthly 0.6 https://novapharmanews.com/eu/news/reuters-pharma-eu-daily-roundup 2026-05-04T05:15:59.427Z monthly 0.6 https://novapharmanews.com/eu/news/reuters-pharma-eu-day-1-highlights 2026-05-04T03:53:30.867Z monthly 0.6 https://novapharmanews.com/eu/news/pharma-news-today-opioid-crisis-drug-pricing-supply-chain 2026-05-04T21:55:20.775Z monthly 0.6 https://novapharmanews.com/eu/news/fda-idvynso-ascentage-asco-2026 2026-05-04T18:12:26.505Z monthly 0.6 https://novapharmanews.com/us/news/aacr-2026-oncology-highlights 2026-05-04T14:01:19.996Z monthly 0.6 https://novapharmanews.com/apac/news/kelun-biotech-sacituzumab-tirumotecan-asco-2026-presentations 2026-05-04T15:15:12.835Z monthly 0.6 https://novapharmanews.com/apac/news/novi-health-glp-1-hybrid-care-model-clinical-real-world-gap 2026-05-04T13:49:22.784Z monthly 0.6 https://novapharmanews.com/apac/news/duchesnay-peripharm-regulatory-reform-womens-health-access-canada 2026-05-04T22:46:59.856Z monthly 0.6 https://novapharmanews.com/apac/news/australia-tga-updates-ivd-regulations-medical-device-manufacturers 2026-05-04T17:18:45.444Z monthly 0.6 https://novapharmanews.com/apac/news/washington-state-life-sciences-industry-growth-2024 2026-05-03T21:41:22.725Z monthly 0.6 https://novapharmanews.com/eu/news/redhill-opaganib-neuroblastoma-triple-negative-breast-cancer-aacr-2026 2026-05-03T20:58:45.764Z monthly 0.6 https://novapharmanews.com/eu/news/redhill-opaganib-neuroblastoma-breast-cancer-aacr-2026 2026-05-04T21:27:06.003Z monthly 0.6 https://novapharmanews.com/eu/news/sab-biotherapeutics-sab-142-c-peptide-preservation-type-1-diabetes-phase-1-trial 2026-05-04T20:56:42.985Z monthly 0.6 https://novapharmanews.com/eu/news/boston-scientific-q1-2026-earnings-clinical-trial-results 2026-05-04T19:54:58.311Z monthly 0.6 https://novapharmanews.com/eu/news/cervomed-neflamapimod-brain-volume-increase-dementia-lewy-bodies-aan-2026 2026-05-04T12:54:10.428Z monthly 0.6 https://novapharmanews.com/eu/news/cervomed-neflamapimod-dementia-lewy-bodies-aan-2026-results 2026-05-04T12:54:10.587Z monthly 0.6 https://novapharmanews.com/eu/news/celerion-thl-partners-majority-investment-clinical-research 2026-05-04T20:57:13.464Z monthly 0.6 https://novapharmanews.com/eu/news/veristat-acquires-certara-regulatory-writing-business-european-expansion 2026-05-03T10:30:31.125Z monthly 0.6 https://novapharmanews.com/eu/news/lung-cancer-therapeutics-market-142-billion-precision-medicine-2036 2026-05-03T23:54:27.660Z monthly 0.6 https://novapharmanews.com/eu/news/drug-delivery-devices-market-growth-forecast-2032-biologics 2026-05-03T20:30:42.833Z monthly 0.6 https://novapharmanews.com/eu/news/polycythemia-vera-market-transformation-protagonist-therapeutics-rusfertide-2036 2026-05-02T17:09:32.069Z monthly 0.6 https://novapharmanews.com/eu/news/ipsen-ojemda-tovorafenib-first-targeted-therapy-pediatric-brain-tumors-eu-approval 2026-05-03T20:17:52.514Z monthly 0.6 https://novapharmanews.com/eu/news/sanofi-tzield-fda-approval-children-type-1-diabetes-delay 2026-05-02T20:15:13.754Z monthly 0.6 https://novapharmanews.com/us/news/denali-therapeutics-fda-approval-avlayah-tividenofusp-alfa-hunter-syndrome 2026-05-03T21:17:16.649Z monthly 0.6 https://novapharmanews.com/us/news/pfizer-lorbrena-braftovi-asco-2026-cancer-trials 2026-05-03T05:35:02.058Z monthly 0.6 https://novapharmanews.com/us/news/capricor-deramiocel-phase-3-hope-3-duchenne-muscular-dystrophy-aan-2026 2026-05-04T13:36:57.274Z monthly 0.6 https://novapharmanews.com/us/news/boston-scientific-q1-2026-earnings-results-revenue-growth 2026-05-04T03:56:33.517Z monthly 0.6 https://novapharmanews.com/us/news/ractigen-rag-17-als-phase-1-trial-results-2026 2026-05-04T05:50:18.987Z monthly 0.6 https://novapharmanews.com/us/news/avacta-ava6103-cancer-drug-aacr-2026-data-enhertu-comparison 2026-05-03T22:53:12.603Z monthly 0.6 https://novapharmanews.com/us/news/innovent-ibi363-clinical-data-asco-2026 2026-05-03T22:51:01.827Z monthly 0.6 https://novapharmanews.com/us/news/fda-extends-sanofi-sarclisa-subcutaneous-review-multiple-myeloma 2026-05-04T02:10:47.898Z monthly 0.6 https://novapharmanews.com/us/news/nrx-pharmaceuticals-fda-feedback-preservative-free-ketamine-generic 2026-05-03T12:24:43.998Z monthly 0.6 https://novapharmanews.com/us/news/lupin-launches-generic-dapagliflozin-metformin-xr-tablets-us-xigduo-alternative 2026-05-04T10:51:30.725Z monthly 0.6 https://novapharmanews.com/us/news/sanofi-tzield-fda-approval-children-type-1-diabetes-delay 2026-05-04T00:06:41.477Z monthly 0.6 https://novapharmanews.com/us/news/fda-approves-sanofi-tzield-children-type-1-diabetes-delay 2026-05-03T17:43:29.644Z monthly 0.6 https://novapharmanews.com/eu/news/pharma-2026-eu-daily-roundup 2026-05-03T22:58:21.207Z monthly 0.6 https://novapharmanews.com/eu/news/pharma-2026-eu-day-1-roundup 2026-05-04T11:58:03.057Z monthly 0.6 https://novapharmanews.com/us/news/generic-drug-forum-us-market-access 2026-05-03T03:57:43.203Z monthly 0.6 https://novapharmanews.com/us/news/interphex-2026-biotech-innovations-day-1 2026-05-04T04:21:38.201Z monthly 0.6 https://novapharmanews.com/us/news/aacr-2024-daily-oncology-research-roundup 2026-05-04T12:51:55.889Z monthly 0.6 https://novapharmanews.com/eu/news/pharma-news-purdue-sentencing-supply-chain-asco 2026-05-03T04:58:45.966Z monthly 0.6 https://novapharmanews.com/us/news/generic-drugs-forum-2026-fda-event-opens 2026-05-04T06:49:07.139Z monthly 0.6 https://novapharmanews.com/us/news/interphex-2026-avantor-biolife-aes-highlights 2026-05-03T22:55:11.805Z monthly 0.6 https://novapharmanews.com/us/news/aacr-2024-oncology-news-day-1 2026-05-03T15:03:44.135Z monthly 0.6 https://novapharmanews.com/us/news/aacr-2024-oncology-research-highlights-day-1 2026-05-04T21:01:27.142Z monthly 0.6 https://novapharmanews.com/eu/news/slas-europe-2026-lab-automation-screening 2026-05-03T04:58:27.491Z monthly 0.6 https://novapharmanews.com/eu/news/pharma-partnering-eu-2026-biotech-bdl-preview 2026-05-04T12:49:41.802Z monthly 0.6 https://novapharmanews.com/us/news/fda-redi-conference-2026-preview 2026-05-04T19:44:30.603Z monthly 0.6 https://novapharmanews.com/us/news/scopex-2026-causal-ai-ml-clinical-trials-preview 2026-05-04T12:52:08.611Z monthly 0.6 https://novapharmanews.com/us/news/pharma-manufacturing-innovation-us-2026 2026-05-04T12:52:36.506Z monthly 0.6 https://novapharmanews.com/eu/news/eu-pharma-innovation-trends-2026 2026-05-04T02:20:42.688Z monthly 0.6 https://novapharmanews.com/us/news/ispor-2026-cardiology-heor-preview 2026-05-04T12:52:33.021Z monthly 0.6 https://novapharmanews.com/us/news/bbsw-ai-solution-2026-biotech-preview 2026-05-03T00:51:01.261Z monthly 0.6 https://novapharmanews.com/us/news/bio-it-world-2026-ai-oncology-preview 2026-05-04T12:51:56.363Z monthly 0.6 https://novapharmanews.com/us/news/ispor-2026-heor-policy-pharma-pricing 2026-05-04T17:49:22.403Z monthly 0.6 https://novapharmanews.com/us/news/2nd-annual-cog-2026-pharma-preview 2026-05-03T04:05:56.842Z monthly 0.6 https://novapharmanews.com/us/news/biomed-israel-2026-preview 2026-05-04T21:13:41.532Z monthly 0.6 https://novapharmanews.com/us/news/asgct-2026-calidi-biotherapeutics-redtail-preview 2026-05-04T22:06:43.685Z monthly 0.6 https://novapharmanews.com/apac/news/pda-apac-pharma-manufacturing-trends-2026 2026-05-04T13:00:48.635Z monthly 0.6 https://novapharmanews.com/eu/news/isct-2026-cell-gene-therapy-manufacturing-dublin 2026-05-04T01:15:29.224Z monthly 0.6 https://novapharmanews.com/us/news/asgct-2026-gene-therapy-preview 2026-05-04T12:52:13.055Z monthly 0.6 https://novapharmanews.com/us/news/asgct-2026-gene-therapy-manufacturing-preview 2026-05-04T12:52:13.035Z monthly 0.6 https://novapharmanews.com/us/news/thma-cpe-circle-2026-pharma-exec-networking 2026-05-03T23:51:26.207Z monthly 0.6 https://novapharmanews.com/us/news/thma-oncology-forum-2026-pharma-insights 2026-05-04T12:51:53.995Z monthly 0.6 https://novapharmanews.com/eu/news/raps-euro-convergence-2026-eu-mdr-regulatory-tech 2026-05-04T12:53:04.773Z monthly 0.6 https://novapharmanews.com/eu/news/european-research-revolution-clinical-trial-tech 2026-05-04T22:46:07.417Z monthly 0.6 https://novapharmanews.com/us/news/aphl-2026-annual-preview 2026-05-04T12:53:02.295Z monthly 0.6 https://novapharmanews.com/eu/news/swiss-biotech-day-2026-preview 2026-05-04T12:49:41.835Z monthly 0.6 https://novapharmanews.com/us/news/excipient-world-2026-preview 2026-05-04T18:25:47.745Z monthly 0.6 https://novapharmanews.com/us/news/pharma-partnering-us-2026-biotech-dealmaking 2026-05-04T22:40:43.891Z monthly 0.6 https://novapharmanews.com/us/news/pharma-partnering-us-summit-2026-preview 2026-04-23T02:01:12.078Z monthly 0.6 https://novapharmanews.com/eu/news/eu-biopharma-clinical-trials-oncology-asco-aua 2026-05-03T18:56:52.257Z monthly 0.6 https://novapharmanews.com/us/news/clinical-outsourcing-trends-2026 2026-05-04T22:45:00.018Z monthly 0.6 https://novapharmanews.com/us/news/4th-annual-cog-preview 2026-05-04T18:53:01.562Z monthly 0.6 https://novapharmanews.com/apac/news/chinabio-partnering-forum-2026-apac-biotech-preview 2026-05-03T18:30:42.445Z monthly 0.6 https://novapharmanews.com/us/news/pharma-compliance-congress-2026-preview 2026-05-04T20:15:54.540Z monthly 0.6 https://novapharmanews.com/us/news/aacr-2026-pembrolizumab-bowel-cancer-moderna-melanoma 2026-05-02T17:10:22.455Z monthly 0.6 https://novapharmanews.com/us/news/aacr-2026-day3-immunotherapy-kras-mrna 2026-05-04T21:16:01.618Z monthly 0.6 https://novapharmanews.com/us/news/acrp-2026-immunology-clinical-research-preview 2026-05-04T11:53:33.570Z monthly 0.6 https://novapharmanews.com/eu/news/reuters-pharma-2024-preview 2026-05-04T13:52:00.417Z monthly 0.6 https://novapharmanews.com/eu/news/reuters-pharma-2024-preview-eu 2026-05-04T02:39:28.799Z monthly 0.6 https://novapharmanews.com/apac/news/suvoda-agentic-ai-rtsm-clinical-trial-startup-reduction 2026-05-04T00:11:27.201Z monthly 0.6 https://novapharmanews.com/apac/news/dayspring-pharma-cg2001-foam-phase-ii-trial-androgenetic-alopecia-results 2026-05-02T18:41:28.578Z monthly 0.6 https://novapharmanews.com/apac/news/myome-board-appointments-healthcare-leaders-ai-genomics 2026-05-04T14:46:42.538Z monthly 0.6 https://novapharmanews.com/apac/news/synbiotech-l-plantarum-fs4722-hyperuricemia-prevention-preclinical 2026-05-03T09:54:14.779Z monthly 0.6 https://novapharmanews.com/apac/news/nasal-sprays-market-29-billion-2036-allergy-growth 2026-05-03T17:56:53.160Z monthly 0.6 https://novapharmanews.com/apac/news/andelyn-biosciences-encell-gene-therapy-manufacturing-partnership 2026-05-04T22:33:30.022Z monthly 0.6 https://novapharmanews.com/apac/news/turbine-crown-bioscience-ai-organoid-cancer-drug-discovery-partnership 2026-05-04T22:45:18.198Z monthly 0.6 https://novapharmanews.com/apac/news/australia-tga-medicinal-cannabis-pediatric-access-guidelines-2024 2026-05-03T21:01:43.927Z monthly 0.6 https://novapharmanews.com/apac/news/australia-tga-unapproved-therapeutic-goods-special-access-scheme-guidance 2026-05-03T07:20:26.558Z monthly 0.6 https://novapharmanews.com/apac/news/ghit-fund-invests-8-5-million-malaria-ntd-drug-development-gsk-eisai 2026-05-03T07:47:11.131Z monthly 0.6 https://novapharmanews.com/apac/news/ghit-fund-8-5-million-malaria-ntd-drug-development-gsk-eisai 2026-05-02T21:00:51.602Z monthly 0.6 https://novapharmanews.com/eu/news/kelun-biotech-sac-tmt-asco-2026-presentations 2026-05-04T06:45:08.810Z monthly 0.6 https://novapharmanews.com/eu/news/prescriberpoint-ai-prior-authorization-platform-clinician-acceptance-rate 2026-05-03T16:20:40.675Z monthly 0.6 https://novapharmanews.com/eu/news/grail-galleri-cancer-detection-asco-2026-results 2026-05-03T06:23:22.336Z monthly 0.6 https://novapharmanews.com/eu/news/eupraxia-pharmaceuticals-positive-resolve-trial-eosinophilic-esophagitis-data 2026-05-04T19:05:01.526Z monthly 0.6 https://novapharmanews.com/eu/news/cellcarta-regask-ai-platform-regulatory-compliance-efficiency 2026-05-04T17:03:31.480Z monthly 0.6 https://novapharmanews.com/eu/news/leerink-partners-medincell-outperform-uzedy-risperidone-lai-fda-approval 2026-05-04T12:54:10.621Z monthly 0.6 https://novapharmanews.com/eu/news/getinge-cardiohelp-ii-ce-mark-intergard-synergy-eu-mdr-approval 2026-05-04T18:59:06.449Z monthly 0.6 https://novapharmanews.com/eu/news/karyopharm-phase-3-sentry-trial-asco-2026-myelofibrosis 2026-05-04T19:23:56.246Z monthly 0.6 https://novapharmanews.com/eu/news/allogene-therapeutics-expands-cemacabtagene-ansegedleucel-alpha3-trial-south-korea-australia 2026-05-04T22:03:25.996Z monthly 0.6 https://novapharmanews.com/eu/news/biocon-health-canada-approval-denosumab-biosimilars-bosaya-vevzuo 2026-05-04T12:54:12.911Z monthly 0.6 https://novapharmanews.com/us/news/francis-medical-vanquish-prostate-ablation-midwest-first-procedure 2026-05-04T21:22:48.169Z monthly 0.6 https://novapharmanews.com/us/news/aquestive-therapeutics-anaphylm-fda-deficiencies-class-action-lawsuit 2026-05-04T19:54:33.522Z monthly 0.6 https://novapharmanews.com/us/news/efemoral-medical-bioresorbable-scaffold-97-percent-patency-peripheral-artery-disease 2026-05-04T01:03:58.781Z monthly 0.6 https://novapharmanews.com/us/news/kyverna-miv-cel-stiff-person-syndrome-trial-results-breakthrough 2026-05-04T01:28:33.600Z monthly 0.6 https://novapharmanews.com/us/news/invera-medical-90-percent-vein-closure-chronic-venous-disease-trial-results 2026-05-04T04:36:09.707Z monthly 0.6 https://novapharmanews.com/us/news/reva-medical-motiv-scaffold-superior-results-critical-limb-ischemia-trial 2026-04-30T06:47:45.969Z monthly 0.6 https://novapharmanews.com/us/news/ractigen-rag-17-als-phase-1-results-neurofilament-reduction 2026-05-04T05:04:46.439Z monthly 0.6 https://novapharmanews.com/us/news/mabwell-nectin-4-adc-bulumtatug-fuvedotin-cervical-cancer-nejm-case-report 2026-05-04T03:40:26.249Z monthly 0.6 https://novapharmanews.com/us/news/outlook-therapeutics-fda-dispute-resolution-lytenava-bevacizumab 2026-05-04T12:50:34.078Z monthly 0.6 https://novapharmanews.com/us/news/follicular-lymphoma-clinical-trials-45-companies-2026 2026-05-04T22:47:43.164Z monthly 0.6 https://novapharmanews.com/us/news/obsidian-therapeutics-obx-115-phase-2-melanoma-asco-2026 2026-05-04T21:19:35.155Z monthly 0.6 https://novapharmanews.com/us/news/icecure-medical-prosense-revenue-increases-30-percent-q1-2026 2026-05-02T20:03:58.427Z monthly 0.6 https://novapharmanews.com/us/news/nuvalent-neladalkib-alkove-1-trial-data-asco-2026-alk-positive-nsclc 2026-05-04T18:39:12.404Z monthly 0.6 https://novapharmanews.com/us/news/fda-approves-merck-idvynso-hiv-treatment-doravirine-islatravir 2026-05-04T22:44:23.117Z monthly 0.6 https://novapharmanews.com/apac/news/peptidream-asahi-kasei-ak1940-phase-1-clinical-trial 2026-05-03T00:29:21.495Z monthly 0.6 https://novapharmanews.com/apac/news/rznomics-rz-001-hepatocellular-carcinoma-trial-results-aacr-2026 2026-05-04T22:33:00.017Z monthly 0.6 https://novapharmanews.com/apac/news/biogen-acquires-felzartamab-tj-biopharma-china 2026-05-04T18:03:21.509Z monthly 0.6 https://novapharmanews.com/apac/news/argo-biopharma-bw-40202-phase-ii-trials-sirna-therapy 2026-05-04T22:33:28.019Z monthly 0.6 https://novapharmanews.com/apac/news/mabwell-bioscience-pics-gmp-inspection-denosumab-biosimilars-jordan 2026-05-04T19:47:03.535Z monthly 0.6 https://novapharmanews.com/apac/news/mabwell-t-mab-jordan-gmp-inspection-denosumab-biosimilars-approval 2026-05-04T09:47:43.382Z monthly 0.6 https://novapharmanews.com/apac/news/quality-executive-partners-vienni-virtuosi-india-pharmaceutical-training 2026-05-04T05:14:42.683Z monthly 0.6 https://novapharmanews.com/apac/news/synsmart-amporin-partnership-small-molecule-therapeutics-degenerative-diseases 2026-05-03T22:28:14.270Z monthly 0.6 https://novapharmanews.com/apac/news/australia-tga-otc-medicine-registration-guidelines-update 2026-05-03T09:54:27.503Z monthly 0.6 https://novapharmanews.com/apac/news/methylphenidate-shortage-update-concerta-ritalin-rubifen-supply-2026 2026-05-04T10:01:52.499Z monthly 0.6 https://novapharmanews.com/apac/news/pmda-approves-peripheral-rotablator-pro-visual-ice-cryoablation-system-japan 2026-05-03T07:05:16.471Z monthly 0.6 https://novapharmanews.com/eu/news/cigna-healthcare-imuldosa-biosimilar-preferred-coverage-accord-biopharma 2026-05-04T21:21:01.087Z monthly 0.6 https://novapharmanews.com/eu/news/briacell-bria-ots-phase-3-breast-cancer-quality-life-aacr-2026 2026-05-03T03:00:28.188Z monthly 0.6 https://novapharmanews.com/eu/news/pharmaceutical-isolators-market-782-billion-eu-gmp-annex-1 2026-05-04T18:25:39.316Z monthly 0.6 https://novapharmanews.com/eu/news/mabwell-pics-gmp-compliance-jordan-fda-biopharmaceutical-manufacturing 2026-05-04T22:55:02.332Z monthly 0.6 https://novapharmanews.com/eu/news/implantica-refluxstop-device-safety-study-602-patients-europe 2026-05-04T12:54:26.946Z monthly 0.6 https://novapharmanews.com/eu/news/askbio-ametefgene-parvec-phase-ii-parkinson-gene-therapy 2026-05-04T12:54:33.947Z monthly 0.6 https://novapharmanews.com/us/news/lenz-therapeutics-vizz-presbyopia-uk-mhra-approval-submission 2026-05-03T21:42:19.487Z monthly 0.6 https://novapharmanews.com/us/news/pasithea-pas-004-fda-rare-pediatric-disease-designation-nf1 2026-05-03T04:30:12.525Z monthly 0.6 https://novapharmanews.com/us/news/clearmind-medicine-cmnd-100-safety-endpoint-alcohol-use-disorder-trial 2026-05-04T05:50:55.761Z monthly 0.6 https://novapharmanews.com/us/news/sapience-therapeutics-st316-phase-2-colorectal-cancer-results 2026-05-03T05:26:04.267Z monthly 0.6 https://novapharmanews.com/us/news/tozorakimab-phase-3-miranda-trial-copd-exacerbations-reduction 2026-05-04T04:21:40.722Z monthly 0.6 https://novapharmanews.com/us/news/abogen-abo2203-mrna-cancer-therapy-b-cell-lymphoma-trial-aacr-2026 2026-05-04T19:25:30.763Z monthly 0.6 https://novapharmanews.com/us/news/verismo-synkir-110-phase-1-trial-results-aacr-2026 2026-04-30T18:31:07.457Z monthly 0.6 https://novapharmanews.com/us/news/inhibrx-ozekibart-inbrx-109-colorectal-cancer-clinical-update-webcast 2026-05-03T09:42:32.759Z monthly 0.6 https://novapharmanews.com/us/news/akeso-cadonilimab-pancreatic-cancer-phase-2-trial-results 2026-05-03T23:34:02.827Z monthly 0.6 https://novapharmanews.com/us/news/debiopharm-lunresertib-fda-fast-track-ovarian-cancer 2026-05-04T10:20:15.993Z monthly 0.6 https://novapharmanews.com/us/news/adcendo-adce-t02-expansion-phase-adce-d01-fda-orphan-drug-designation 2026-05-03T06:05:18.971Z monthly 0.6 https://novapharmanews.com/us/news/fda-accepts-genentech-gazyva-lupus-treatment-application 2026-05-03T05:23:51.690Z monthly 0.6 https://novapharmanews.com/us/news/fda-priority-review-padcev-keytruda-bladder-cancer-astellas 2026-05-03T12:34:34.741Z monthly 0.6 https://novapharmanews.com/us/news/fda-approval-dermaclear-severe-acne-2026 2026-05-04T12:50:21.223Z monthly 0.6 https://novapharmanews.com/us/news/fda-approves-cell-therapy-multiple-sclerosis-2024 2026-05-04T20:52:33.345Z monthly 0.6 https://novapharmanews.com/us/news/fda-biosimilar-substitution-policy-update-2024 2026-05-04T14:47:32.582Z monthly 0.6 https://novapharmanews.com/eu/news/ema-biosimilar-policy-impact-2024 2026-05-04T20:03:01.675Z monthly 0.6 https://novapharmanews.com/us/news/fda-approval-paxlovid-covid19-treatment-eua-2024 2026-05-02T16:13:29.769Z monthly 0.6 https://novapharmanews.com/us/news/fda-approval-riabni-rituximab-biosimilar-nhl-2024 2026-05-04T21:50:37.638Z monthly 0.6 https://novapharmanews.com/us/news/fda-approval-adagrasib-kras-g12c-nsclc-2024 2026-05-04T22:35:36.265Z monthly 0.6 https://novapharmanews.com/us/news/fda-approves-apretude-injectable-prep-hiv-2024 2026-05-04T21:48:12.781Z monthly 0.6 https://novapharmanews.com/us/news/fda-approves-skin-renew-new-indication-severe-eczema-2024 2026-05-03T22:59:02.814Z monthly 0.6 https://novapharmanews.com/us/news/fda-update-diabetes-therapy-label-warning-2024 2026-05-04T12:50:21.434Z monthly 0.6 https://novapharmanews.com/us/news/fda-approves-genopharm-geno-cure-targeted-cancer-2024 2026-05-04T01:08:02.347Z monthly 0.6 https://novapharmanews.com/us/news/fda-approves-allerclear-otc-seasonal-allergies-2024 2026-05-04T12:50:21.434Z monthly 0.6 https://novapharmanews.com/us/news/fda-approves-bact-away-antibiotic-resistant-infections-2024 2026-05-02T20:48:57.916Z monthly 0.6 https://novapharmanews.com/us/news/fda-approval-algorithma-algo-1-trd-2024 2026-05-04T20:49:03.657Z monthly 0.6 https://novapharmanews.com/us/news/fda-approves-trial-update-semaglutide-obesity-2024 2026-05-04T12:52:02.140Z monthly 0.6 https://novapharmanews.com/apac/news/alamar-biosciences-nasdaq-ipo-precision-proteomics-debut 2026-05-02T15:21:08.547Z monthly 0.6 https://novapharmanews.com/apac/news/act-genomics-101-gene-panel-cancer-testing-upgrade-2026 2026-05-04T20:17:55.523Z monthly 0.6 https://novapharmanews.com/apac/news/qdenga-dengue-vaccine-approved-australia-tga-four-serotypes 2026-05-04T15:02:09.801Z monthly 0.6 https://novapharmanews.com/eu/news/ema-iris-psur-submission-requirements-september-2025 2026-05-04T20:30:24.719Z monthly 0.6 https://novapharmanews.com/us/news/revolution-medicines-zoldonrasib-phase-1-data-kras-g12d-lung-cancer-aacr-2026 2026-05-01T01:02:15.817Z monthly 0.6 https://novapharmanews.com/us/news/epibiologics-epi-326-phase-1-trial-egfr-cancer 2026-05-03T20:57:15.986Z monthly 0.6 https://novapharmanews.com/us/news/sbc-medical-group-secondary-offering-3-1-million-shares 2026-05-04T21:08:17.912Z monthly 0.6 https://novapharmanews.com/us/news/fda-terminates-gas-delivery-engine-ventilator-recall-16650a 2026-05-04T06:19:18.840Z monthly 0.6 https://novapharmanews.com/us/news/philip-morris-iqos-fda-reauthorization-modified-risk-tobacco-product 2026-05-01T21:26:56.452Z monthly 0.6 https://novapharmanews.com/us/news/ascentage-pharma-preclinical-cancer-studies-aacr-2026 2026-05-04T00:15:07.773Z monthly 0.6 https://novapharmanews.com/us/news/whitehawk-therapeutics-hwk-007-adc-data-aacr-2026 2026-05-04T21:48:46.283Z monthly 0.6 https://novapharmanews.com/us/news/pulnovo-medical-100-million-medtronic-investment-pulmonary-hypertension 2026-05-04T21:01:23.793Z monthly 0.6 https://novapharmanews.com/us/news/nuance-pharma-ohtuvayre-enhance-china-phase-3-copd-results-chest-journal 2026-05-04T13:49:39.582Z monthly 0.6 https://novapharmanews.com/us/news/lundbeck-vyepti-migraine-cognitive-symptoms-infuse-study-2026 2026-05-04T03:35:02.789Z monthly 0.6 https://novapharmanews.com/us/news/fda-approval-biosimilar-clone-remicade-2026 2026-05-04T12:50:34.261Z monthly 0.6 https://novapharmanews.com/us/news/fda-priority-review-arterioflow-pad-2024 2026-05-04T12:50:21.580Z monthly 0.6 https://novapharmanews.com/us/news/fda-approves-v-protect-vaccine-2026 2026-05-04T20:54:06.069Z monthly 0.6 https://novapharmanews.com/us/news/fda-approval-inno-med-inhaler-tech-asthma-2024 2026-05-03T12:42:53.044Z monthly 0.6 https://novapharmanews.com/us/news/fda-approves-duo-boost-type-2-diabetes-2024 2026-05-04T21:39:09.718Z monthly 0.6 https://novapharmanews.com/us/news/fda-approval-rgen-101-raregen-orphan-drug-2024 2026-05-04T01:36:48.707Z monthly 0.6 https://novapharmanews.com/us/news/fda-approves-inflammex-ulcerative-colitis-2026 2026-05-04T17:56:33.735Z monthly 0.6 https://novapharmanews.com/us/news/fda-approves-synapton-alzheimers-2026 2026-05-03T17:40:24.457Z monthly 0.6 https://novapharmanews.com/us/news/fda-approval-generic-epipen-mylan-2024 2026-05-04T12:50:22.842Z monthly 0.6 https://novapharmanews.com/us/news/fda-approves-prevnar-20-pediatric-indication-2024 2026-05-04T12:50:23.022Z monthly 0.6 https://novapharmanews.com/apac/news/zai-lab-zl-1503-bispecific-antibody-itch-relief-atopic-diseases 2026-05-04T05:18:08.862Z monthly 0.6 https://novapharmanews.com/apac/news/zai-lab-zl-1503-bispecific-antibody-atopic-disease-itch-relief-preclinical-data 2026-05-03T22:16:41.603Z monthly 0.6 https://novapharmanews.com/apac/news/antengene-novel-cancer-programs-aacr-2026-adc-tce-therapies 2026-05-04T06:07:27.392Z monthly 0.6 https://novapharmanews.com/apac/news/antengene-adc-antengager-tce-programs-aacr-2026 2026-05-04T16:00:52.539Z monthly 0.6 https://novapharmanews.com/apac/news/australia-tga-therapeutic-vaping-pharmacy-access-regulatory-framework 2026-05-04T22:11:31.542Z monthly 0.6 https://novapharmanews.com/apac/news/tga-medical-device-regulations-ai-software-therapeutic-products-australia 2026-05-03T18:31:56.417Z monthly 0.6 https://novapharmanews.com/eu/news/adagene-muzastotug-triple-combination-therapy-hepatocellular-carcinoma-aacr-2026 2026-04-30T23:43:53.739Z monthly 0.6 https://novapharmanews.com/eu/news/hytn-innovations-hard-cannabis-remediation-technology-gmp-processing-germany 2026-05-03T12:48:10.220Z monthly 0.6 https://novapharmanews.com/eu/news/sanofi-nuvaxovid-covid-vaccine-better-tolerability-mnexspike-phase-4-study 2026-05-03T09:43:51.242Z monthly 0.6 https://novapharmanews.com/eu/news/brand-institute-ema-approval-ai-pharmaceutical-branding-brandi-platform 2026-05-04T18:14:43.940Z monthly 0.6 https://novapharmanews.com/eu/news/ema-drug-patent-cliff-2026-european-exclusivities-expire 2026-05-04T11:31:25.666Z monthly 0.6 https://novapharmanews.com/eu/news/ema-chmp-recommends-six-new-medicines-approval-february-2024 2026-05-04T12:54:31.624Z monthly 0.6 https://novapharmanews.com/eu/news/ema-recommends-adstiladrin-gene-therapy-bladder-cancer-march-2026 2026-05-04T22:25:44.996Z monthly 0.6 https://novapharmanews.com/us/news/health-canada-approves-bracco-vueway-gadopiclenol-mri-contrast 2026-05-02T07:33:57.771Z monthly 0.6 https://novapharmanews.com/us/news/salubris-jk06-phase-1-2-cancer-trial-aacr-2024 2026-05-02T23:24:44.117Z monthly 0.6 https://novapharmanews.com/us/news/innate-pharma-iph5201-matisse-phase-2-aacr-2026-plenary-session 2026-04-30T11:39:41.330Z monthly 0.6 https://novapharmanews.com/us/news/accent-therapeutics-atx-295-kif18a-inhibitor-aacr-2026-cancer-data 2026-05-04T19:41:35.689Z monthly 0.6 https://novapharmanews.com/us/news/zai-lab-zl-1503-bispecific-antibody-atopic-disease-itch-relief 2026-05-04T21:08:30.156Z monthly 0.6 https://novapharmanews.com/us/news/zai-lab-zl-1503-bispecific-antibody-itch-relief-atopic-dermatitis-preclinical 2026-05-04T19:36:24.603Z monthly 0.6 https://novapharmanews.com/us/news/fda-reauthorizes-philip-morris-iqos-modified-risk-tobacco-product 2026-05-04T03:10:40.549Z monthly 0.6 https://novapharmanews.com/us/news/zai-lab-zl-1503-bispecific-antibody-itch-relief-atopic-disease-preclinical-data 2026-05-04T00:13:59.506Z monthly 0.6 https://novapharmanews.com/us/news/olema-oncology-palazestrant-op-3136-preclinical-data-aacr-2026 2026-05-02T11:29:42.830Z monthly 0.6 https://novapharmanews.com/us/news/ucb-acquires-neurona-therapeutics-nrtx-1001-epilepsy-cell-therapy 2026-05-04T19:05:41.717Z monthly 0.6 https://novapharmanews.com/us/news/xodus-medical-fda-clearance-hot-pink-pad-surgical-temperature-management 2026-05-02T21:00:30.608Z monthly 0.6 https://novapharmanews.com/us/news/argenx-vyvgart-myasthenia-gravis-cidp-aan-2026-clinical-data 2026-05-03T20:21:58.326Z monthly 0.6 https://novapharmanews.com/us/news/nuvalent-zidesamtinib-ros1-lung-cancer-aacr-2026 2026-05-04T21:05:42.773Z monthly 0.6 https://novapharmanews.com/us/news/fda-approval-verapamil-extended-release-hypertension-2024 2026-05-04T12:52:33.492Z monthly 0.6 https://novapharmanews.com/us/news/fda-approval-imgn-901-breakthrough-therapy-aml-2026 2026-05-04T16:16:33.089Z monthly 0.6 https://novapharmanews.com/us/news/fda-approval-revitan-gene-therapy-sma-type-3-2026 2026-05-04T20:57:15.513Z monthly 0.6 https://novapharmanews.com/us/news/fda-approval-mito-x-accelerated-approval-2024 2026-05-04T18:43:58.527Z monthly 0.6 https://novapharmanews.com/us/news/fda-approval-xylocor-refractory-angina-2026 2026-05-03T06:54:31.096Z monthly 0.6 https://novapharmanews.com/apac/news/atara-biotherapeutics-class-action-lawsuit-atra-stockholders-losses 2026-05-03T17:51:34.722Z monthly 0.6 https://novapharmanews.com/eu/news/ema-approves-hanmi-hmpl-523-alzheimer-herbal-medicine 2026-05-04T22:29:48.567Z monthly 0.6 https://novapharmanews.com/eu/news/gene-therapy-market-growth-crispr-aav-technologies-2034 2026-05-04T12:54:34.350Z monthly 0.6 https://novapharmanews.com/eu/news/healthcare-cold-chain-logistics-market-growth-2034-biopharmaceuticals-asia-pacific 2026-05-03T07:40:38.836Z monthly 0.6 https://novapharmanews.com/eu/news/aim-immunotech-ampligen-phase-3-pancreatic-cancer-trial-orphan-drug 2026-05-04T05:05:17.457Z monthly 0.6 https://novapharmanews.com/eu/news/ab-science-masitinib-als-phase-3-trial-insurance-25-million 2026-05-03T22:53:08.970Z monthly 0.6 https://novapharmanews.com/eu/news/meiragTx-acquires-botaretigene-sparoparvovec-gene-therapy-xlrp-johnson-johnson 2026-05-04T22:41:32.766Z monthly 0.6 https://novapharmanews.com/eu/news/beamion-zongertinib-fda-approval-her2-mutant-nsclc-lung-1-study 2026-05-03T10:41:08.474Z monthly 0.6 https://novapharmanews.com/eu/news/tri-611-fda-fast-track-alk-positive-nsclc-eisai-taletrectinib 2026-05-03T20:42:42.640Z monthly 0.6 https://novapharmanews.com/us/news/maia-biotechnology-phase-2-nsclc-telomere-treatment-trial-us-site 2026-05-04T06:34:47.510Z monthly 0.6 https://novapharmanews.com/us/news/dr-falk-pharma-renexxion-naronapride-phase-2b-gastroparesis-ddw-2026 2026-05-04T22:30:04.044Z monthly 0.6 https://novapharmanews.com/us/news/lilly-foundayo-orforglipron-achieve-4-trial-results-mortality-reduction 2026-05-04T15:50:55.894Z monthly 0.6 https://novapharmanews.com/us/news/aicuris-pritelivir-fda-priority-review-herpes-treatment 2026-05-04T23:01:57.890Z monthly 0.6 https://novapharmanews.com/us/news/medera-aav-serca2a-fda-fast-track-duchenne-cardiomyopathy 2026-05-04T18:28:53.792Z monthly 0.6 https://novapharmanews.com/us/news/boehringer-ingelheim-zongertinib-her2-mutant-lung-cancer-nejm-study 2026-05-03T03:45:43.877Z monthly 0.6 https://novapharmanews.com/us/news/fda-approval-mindbalance-digital-therapeutic-2026 2026-05-04T12:50:23.072Z monthly 0.6 https://novapharmanews.com/us/news/fda-approval-cancervax-adjuvant-melanoma-2026 2026-05-04T20:08:29.543Z monthly 0.6 https://novapharmanews.com/us/news/fda-approval-painblock-patch-chronic-pain-2024 2026-05-03T05:22:44.196Z monthly 0.6 https://novapharmanews.com/us/news/fda-approves-renalprotect-expanded-use-dkd-2024 2026-05-01T10:36:56.305Z monthly 0.6 https://novapharmanews.com/us/news/fda-approval-lungrx-inhaled-therapy-pulmonary-hypertension-2026 2026-05-04T12:35:29.963Z monthly 0.6 https://novapharmanews.com/apac/news/sanyou-ai-stal-2-antibody-discovery-14-days-drug-development 2026-05-03T05:26:05.866Z monthly 0.6 https://novapharmanews.com/apac/news/gene-expression-analysis-market-593-billion-2031-drug-discovery 2026-05-04T22:33:32.022Z monthly 0.6 https://novapharmanews.com/apac/news/perceptive-discovery-mh3d-alpha-sight-radiopharmaceutical-imaging 2026-05-04T09:00:05.362Z monthly 0.6 https://novapharmanews.com/apac/news/pg-health-apac-pharmacist-guidelines-peripheral-neuropathy-management 2026-05-04T18:13:21.745Z monthly 0.6 https://novapharmanews.com/apac/news/tga-assessed-listed-medicines-framework-update-australia 2026-05-04T13:50:12.546Z monthly 0.6 https://novapharmanews.com/apac/news/corcept-therapeutics-relacorilant-fda-rejection-investor-lawsuit-2025 2026-05-04T22:46:31.224Z monthly 0.6 https://novapharmanews.com/apac/news/florida-cancer-specialists-medically-integrated-oncology-care-2024 2026-05-04T10:26:32.191Z monthly 0.6 https://novapharmanews.com/eu/news/traws-pharma-tivoxavir-marboxil-influenza-trial-ratutrelvir-covid-results-2025 2026-05-04T01:49:52.209Z monthly 0.6 https://novapharmanews.com/eu/news/tme-pharma-nox-a12-triple-therapy-brain-cancer-gloria-trial-nature-communications 2026-05-04T22:50:41.712Z monthly 0.6 https://novapharmanews.com/eu/news/additional-risk-minimization-measures-armms-training-course-patient-safety 2026-05-04T12:54:31.996Z monthly 0.6 https://novapharmanews.com/eu/news/healthcare-logistics-market-growth-159-billion-2030-biopharmaceutical-cold-chain 2026-05-04T23:06:52.109Z monthly 0.6 https://novapharmanews.com/eu/news/medical-device-software-compliance-training-eu-mdr-ivdr-fda-june-2026 2026-05-04T12:54:26.985Z monthly 0.6 https://novapharmanews.com/eu/news/onward-medical-40-million-capital-increase-eqt-life-sciences 2026-05-04T22:00:41.379Z monthly 0.6 https://novapharmanews.com/eu/news/sahpra-african-medicines-agency-regulatory-harmonization-course-may-2026 2026-05-04T17:09:12.295Z monthly 0.6 https://novapharmanews.com/eu/news/bavarian-nordic-vimkunya-chikungunya-vaccine-swiss-approval-swissmedic 2026-05-04T22:43:58.949Z monthly 0.6 https://novapharmanews.com/eu/news/seragon-srn-901-longevity-drug-lifespan-extension-preclinical-study 2026-05-03T18:55:45.710Z monthly 0.6 https://novapharmanews.com/us/news/fda-food-additive-contact-substance-regulatory-updates-2026 2026-05-04T12:52:17.316Z monthly 0.6 https://novapharmanews.com/us/news/recognition-health-alzheimers-blood-test-clinical-trial-2026 2026-05-03T00:06:06.101Z monthly 0.6 https://novapharmanews.com/us/news/mabwell-maiweijian-denosumab-nmpa-acceptance-cancer-bone-metastases 2026-05-04T03:55:29.275Z monthly 0.6 https://novapharmanews.com/us/news/sedogen-diazoxide-patent-prader-willi-syndrome-behavioral-symptoms 2026-05-04T09:47:04.338Z monthly 0.6 https://novapharmanews.com/us/news/mabwell-lilrb4-cd3-bispecific-antibody-6mw5311-nmpa-ind-approval-leukemia 2026-05-03T22:47:17.231Z monthly 0.6 https://novapharmanews.com/us/news/mabwell-maiweijian-denosumab-nmpa-acceptance-cancer-bone-treatment 2026-05-03T23:51:44.634Z monthly 0.6 https://novapharmanews.com/us/news/thinktrends-ai-federal-health-agency-adverse-event-monitoring-system 2026-05-03T06:25:08.340Z monthly 0.6 https://novapharmanews.com/us/news/fullscript-journeys-digital-health-platform-launch-2024 2026-05-04T00:12:12.429Z monthly 0.6 https://novapharmanews.com/us/news/nexalin-technology-fda-alzheimers-strategy-meetings-china-us 2026-05-04T09:55:30.103Z monthly 0.6 https://novapharmanews.com/us/news/immunitybio-ibrx-fda-warning-letter-class-action-lawsuit-ankt 2026-05-03T04:34:47.156Z monthly 0.6 https://novapharmanews.com/us/news/fda-warning-letters-pharmaceutical-compliance-drug-safety-2024 2026-05-03T04:01:32.071Z monthly 0.6 https://novapharmanews.com/us/news/gsk-depemokimab-european-chinese-approval-ultra-long-acting-biologic 2026-05-03T09:17:09.893Z monthly 0.6 https://novapharmanews.com/us/news/elion-therapeutics-turletricin-phase-2-trial-invasive-mold-infections 2026-05-04T06:28:57.783Z monthly 0.6 https://novapharmanews.com/us/news/glaukos-epioxa-permanent-j-code-j2789-cms-approval 2026-05-04T22:58:01.340Z monthly 0.6 https://novapharmanews.com/us/news/nkarta-fda-approval-outpatient-nkx019-dosing-autoimmune-disease 2026-05-04T21:10:09.329Z monthly 0.6 https://novapharmanews.com/apac/news/phantom-neuro-phantom-x-first-human-trial-approval-australia 2026-05-02T07:26:25.235Z monthly 0.6 https://novapharmanews.com/eu/news/boehringer-ingelheim-zai-lab-dll3-targeting-combination-therapy-small-cell-lung-cancer-trial 2026-05-03T02:46:36.832Z monthly 0.6 https://novapharmanews.com/eu/news/imvt-1402-myasthenia-gravis-treatment-pipeline-2026 2026-05-04T05:55:20.254Z monthly 0.6 https://novapharmanews.com/us/news/dogwood-therapeutics-sp16-fda-ind-approval-chemotherapy-pain 2026-05-03T09:34:24.217Z monthly 0.6 https://novapharmanews.com/us/news/pds-biotech-pds01adc-78-percent-response-rate-colorectal-cancer-phase-2 2026-05-04T16:14:58.744Z monthly 0.6 https://novapharmanews.com/us/news/neffy-epinephrine-nasal-spray-approved-canada-needle-free-anaphylaxis-treatment 2026-05-03T22:37:47.767Z monthly 0.6 https://novapharmanews.com/us/news/cala-fda-clearance-kiq-plus-wearable-device-essential-tremor-parkinsons 2026-05-03T07:50:48.047Z monthly 0.6 https://novapharmanews.com/us/news/fda-approves-rapiblyk-landiolol-pediatric-svt-aop-health 2026-05-04T22:30:06.180Z monthly 0.6 https://novapharmanews.com/us/news/asco-2026-gi-innovation-gi-101a-phase-1-data-preview 2026-05-04T06:22:59.776Z monthly 0.6 https://novapharmanews.com/us/news/fda-approval-sleepwell-chronic-insomnia-2026 2026-05-03T21:23:21.770Z monthly 0.6 https://novapharmanews.com/us/news/fda-approval-nanopharm-metastatic-breast-cancer-2024 2026-05-04T18:32:20.584Z monthly 0.6 https://novapharmanews.com/us/news/fda-approval-fluguard-novel-influenza-vaccine-2026 2026-05-03T01:28:45.042Z monthly 0.6 https://novapharmanews.com/us/news/fda-approves-cardiodetect-ai-diagnostic-arrhythmia-2026 2026-05-04T10:58:44.471Z monthly 0.6 https://novapharmanews.com/apac/news/phrontline-biopharma-tj106-her2-adc-preclinical-data-aacr-2026 2026-05-04T22:21:19.800Z monthly 0.6 https://novapharmanews.com/apac/news/xellsmart-xs411-parkinsons-cell-therapy-phase-ii-trial-2026 2026-05-04T01:57:23.081Z monthly 0.6 https://novapharmanews.com/apac/news/peer-ai-regulatory-platform-predictive-intelligence-life-sciences 2026-05-04T08:50:55.860Z monthly 0.6 https://novapharmanews.com/apac/news/wuxi-biologics-iso-13485-certification-drug-device-combination-products 2026-05-04T03:55:27.616Z monthly 0.6 https://novapharmanews.com/apac/news/atelerix-jh-health-partnership-cell-preservation-middle-east 2026-05-04T19:50:57.211Z monthly 0.6 https://novapharmanews.com/apac/news/chitosan-market-growth-kitozyme-primex-pharmaceutical-biopolymer-2036 2026-05-03T18:32:06.550Z monthly 0.6 https://novapharmanews.com/apac/news/telix-tlx101-tx-phase-3-glioblastoma-trial-first-patient 2026-05-04T21:22:02.158Z monthly 0.6 https://novapharmanews.com/apac/news/nmn-500mg-energy-support-tga-approval-australia 2026-05-04T21:54:28.476Z monthly 0.6 https://novapharmanews.com/eu/news/drug-development-services-market-31-billion-2026-pharma-rd-investments 2026-05-02T01:34:36.983Z monthly 0.6 https://novapharmanews.com/eu/news/medicenna-bizaxofusp-brain-cancer-trials-2026-investor-conference 2026-05-02T00:36:06.459Z monthly 0.6 https://novapharmanews.com/eu/news/vitestro-autonomous-robotic-phlebotomy-device-clinical-trial-results 2026-05-03T02:14:53.802Z monthly 0.6 https://novapharmanews.com/eu/news/grace-therapeutics-gtx-104-phase-3-strive-on-trial-aan-2026 2026-05-02T19:40:00.066Z monthly 0.6 https://novapharmanews.com/eu/news/mena-medical-device-regulatory-training-course-may-2026 2026-05-04T12:54:32.167Z monthly 0.6 https://novapharmanews.com/eu/news/cmo-cdmo-market-growth-biologics-manufacturing-2035 2026-05-04T21:13:59.636Z monthly 0.6 https://novapharmanews.com/eu/news/clinical-trial-monitoring-gcp-compliance-course-2026 2026-05-04T02:15:05.067Z monthly 0.6 https://novapharmanews.com/eu/news/gcp-inspections-training-course-ich-e6-r3-eu-ctr-compliance-july-2026 2026-05-03T21:30:24.885Z monthly 0.6 https://novapharmanews.com/eu/news/vabysmo-market-report-2026-roche-eye-drug-growth-forecast 2026-05-03T23:04:18.936Z monthly 0.6 https://novapharmanews.com/eu/news/glyconex-gnx1021-pmda-approval-phase-1-trial-gastrointestinal-cancers 2026-05-04T19:50:21.583Z monthly 0.6 https://novapharmanews.com/us/news/psoriasis-clinical-trial-pipeline-90-companies-2026 2026-05-04T19:45:05.510Z monthly 0.6 https://novapharmanews.com/us/news/meiragTx-aav-haqp1-gene-therapy-xerostomia-3-year-data-april-2026 2026-05-04T15:12:06.918Z monthly 0.6 https://novapharmanews.com/us/news/corbus-pharmaceuticals-crb-913-obesity-drug-canyon-1-trial-enrollment-complete 2026-05-04T22:03:03.381Z monthly 0.6 https://novapharmanews.com/us/news/actuate-therapeutics-elraglusib-pancreatic-cancer-survival-nature-medicine 2026-05-01T22:29:42.253Z monthly 0.6 https://novapharmanews.com/us/news/dupont-amberchrom-xt-sl-chromatography-resins-biopharmaceutical-manufacturing 2026-05-04T20:59:33.304Z monthly 0.6 https://novapharmanews.com/us/news/vasa-therapeutics-lilly-tunelab-ai-camkii-inhibitor-partnership 2026-05-04T18:02:12.691Z monthly 0.6 https://novapharmanews.com/us/news/synusight-biotech-sst001-alpha-synuclein-pet-tracer-nmpa-approval-phase-1-trial 2026-05-03T04:17:27.375Z monthly 0.6 https://novapharmanews.com/us/news/oryon-cell-therapies-appoints-burkhard-blank-chief-medical-officer 2026-05-02T03:52:13.027Z monthly 0.6 https://novapharmanews.com/us/news/amneal-launches-albuterol-beclomethasone-respiratory-inhalers-2026 2026-05-04T18:30:42.089Z monthly 0.6 https://novapharmanews.com/us/news/bright-path-fy2027-budget-domestic-pharmaceutical-manufacturing 2026-05-04T03:55:33.884Z monthly 0.6 https://novapharmanews.com/us/news/partner-therapeutics-bizengri-fda-application-cholangiocarcinoma-nrg1-fusion 2026-05-04T22:06:40.826Z monthly 0.6 https://novapharmanews.com/us/news/clearmind-medicine-cmnd-100-alcohol-use-disorder-trial-results 2026-05-04T01:26:47.920Z monthly 0.6 https://novapharmanews.com/us/news/praxis-precision-medicines-fda-accepts-ulixacaltamide-hcl-essential-tremor-nda 2026-05-03T03:55:58.237Z monthly 0.6 https://novapharmanews.com/us/news/fda-approves-filspari-sparsentan-fsgs-first-treatment-rare-kidney-disease 2026-05-04T20:06:51.569Z monthly 0.6 https://novapharmanews.com/us/news/apotex-fda-approval-generic-infuvite-adult-injection-exclusivity 2026-05-04T21:34:48.697Z monthly 0.6 https://novapharmanews.com/us/news/fda-approves-orphan-drug-rarecure-ert-2026 2026-05-04T11:38:10.644Z monthly 0.6 https://novapharmanews.com/us/news/fda-approves-migraease-new-migraine-drug-2024 2026-05-04T19:36:28.458Z monthly 0.6 https://novapharmanews.com/us/news/fda-approves-expanded-indication-elahere-2024 2026-05-02T21:33:13.479Z monthly 0.6 https://novapharmanews.com/us/news/fda-approval-cardioshield-hfpef-2026 2026-05-04T16:53:17.988Z monthly 0.6 https://novapharmanews.com/us/news/fda-approves-vitacorp-antibiotic-priority-review-2024 2026-05-03T20:33:32.143Z monthly 0.6 https://novapharmanews.com/us/news/fda-approval-neurovance-xr-pediatric-adhd-2026 2026-05-04T21:55:31.301Z monthly 0.6 https://novapharmanews.com/us/news/fda-approval-lumagen-gene-therapy-2024 2026-05-04T16:18:05.548Z monthly 0.6 https://novapharmanews.com/us/news/fda-approves-biosimilar-insulin-lispro-biosolve-2026 2026-05-04T21:48:24.617Z monthly 0.6 https://novapharmanews.com/us/news/fda-accelerated-approval-oncocure-trk-inhibitor-2024 2026-05-04T21:57:03.277Z monthly 0.6 https://novapharmanews.com/us/news/fda-approves-cart-t20-car-t-therapy-mantle-cell-lymphoma-2026 2026-05-04T19:06:54.502Z monthly 0.6 https://novapharmanews.com/eu/news/ema-implement-ai-system-drug-safety-2024 2026-05-04T12:54:15.222Z monthly 0.6 https://novapharmanews.com/eu/news/european-commission-launches-blockchain-pilot-pharmaceutical-supply-chain-2024 2026-05-04T12:54:15.249Z monthly 0.6 https://novapharmanews.com/apac/news/nmepa-priority-review-ai-diagnostic-early-cancer-2024 2026-05-04T21:50:15.492Z monthly 0.6 https://novapharmanews.com/apac/news/pmda-approval-ai-platform-personalized-medicine-oncology-2024 2026-05-04T12:00:36.545Z monthly 0.6 https://novapharmanews.com/us/news/fda-launches-blockchain-pilot-program-pharmaceutical-supply-chain-2024 2026-05-04T06:56:02.585Z monthly 0.6 https://novapharmanews.com/us/news/fda-implement-ai-powered-expedited-drug-review-2027 2026-05-04T22:01:31.135Z monthly 0.6 https://novapharmanews.com/us/news/fda-approves-renoprotect-diabetic-kidney-disease-therapy-2024 2026-05-03T08:49:10.705Z monthly 0.6 https://novapharmanews.com/us/news/fda-approval-airflow-inhalable-severe-asthma-2026 2026-05-04T08:53:31.558Z monthly 0.6 https://novapharmanews.com/us/news/fda-approves-osteobuild-bone-building-agent-severe-osteoporosis-2026 2026-05-02T20:37:58.496Z monthly 0.6 https://novapharmanews.com/us/news/fda-approves-arterioflow-peripheral-artery-disease-2026 2026-05-04T21:32:32.560Z monthly 0.6 https://novapharmanews.com/us/news/fda-priority-review-cholesterolrx-high-cholesterol-2024 2026-05-03T22:50:06.710Z monthly 0.6 https://novapharmanews.com/us/news/fda-approves-opti-sight-glaucoma-2026 2026-05-04T12:52:00.732Z monthly 0.6 https://novapharmanews.com/us/news/fda-approval-microbalance-crohns-disease-2026 2026-05-03T23:09:45.947Z monthly 0.6 https://novapharmanews.com/us/news/fda-approves-somnirestore-chronic-insomnia-2026 2026-05-04T21:53:56.096Z monthly 0.6 https://novapharmanews.com/us/news/fda-approves-neurobloc-non-opioid-pain-reliever-2026 2026-05-04T18:26:08.293Z monthly 0.6 https://novapharmanews.com/us/news/fda-approves-lysoclear-lysosomal-storage-disorders-2026 2026-05-04T21:59:50.077Z monthly 0.6 https://novapharmanews.com/apac/news/nmpa-priority-review-drugname-lung-cancer-2024 2026-05-03T11:19:50.335Z monthly 0.6 https://novapharmanews.com/apac/news/pmda-approves-[drug-name]-sakigake-[disease]-2024 2026-05-03T20:57:23.269Z monthly 0.6 https://novapharmanews.com/eu/news/chmp-positive-opinion-immunotherapy-lung-cancer-2024 2026-05-04T22:04:49.915Z monthly 0.6 https://novapharmanews.com/eu/news/ema-conditional-approval-car-t-relapsed-b-cell-lymphoma-2024 2026-05-04T12:54:15.623Z monthly 0.6 https://novapharmanews.com/us/news/fda-breakthrough-therapy-targtex-tx202-glioblastoma-2024 2026-05-04T04:47:52.694Z monthly 0.6 https://novapharmanews.com/us/news/fda-approves-bria-cell-bria-imt-car-t-therapy-advanced-breast-cancer-2024 2026-05-04T22:34:41.919Z monthly 0.6 https://novapharmanews.com/eu/news/ema-positive-opinion-zepzelca-lurbinectedin-cancer-treatment 2026-05-04T15:30:57.427Z monthly 0.6 https://novapharmanews.com/eu/news/ema-positive-opinion-amgen-tarlatamab-imdylltra-small-cell-lung-cancer 2026-05-04T22:17:49.831Z monthly 0.6 https://novapharmanews.com/eu/news/ema-positive-opinion-adstiladrin-gene-therapy-bladder-cancer 2026-05-04T16:47:33.433Z monthly 0.6 https://novapharmanews.com/eu/news/ema-recommends-imdylltra-tarlatamab-small-cell-lung-cancer-approval 2026-05-04T15:48:54.095Z monthly 0.6 https://novapharmanews.com/eu/news/ema-virtual-control-groups-reduce-animal-testing-drug-development 2026-05-04T07:52:11.384Z monthly 0.6 https://novapharmanews.com/us/news/fda-manufacturing-precheck-pilot-program-streamline-oversight 2026-05-02T01:47:31.659Z monthly 0.6 https://novapharmanews.com/us/news/real-world-evidence-transforms-drug-development-fda-regulatory-framework 2026-05-04T12:52:17.693Z monthly 0.6 https://novapharmanews.com/us/news/fda-untitled-letters-pharmaceutical-marketing-violations-database 2026-05-04T15:57:52.288Z monthly 0.6 https://novapharmanews.com/us/news/fda-approves-higher-dose-wegovy-7-2mg-weight-loss-priority-review 2026-05-03T03:47:22.483Z monthly 0.6 https://novapharmanews.com/us/news/fda-approves-avlayah-hunter-syndrome-neurologic-treatment 2026-05-04T22:38:43.891Z monthly 0.6 https://novapharmanews.com/us/news/fda-approves-kresladi-first-gene-therapy-lad-i-leukocyte-adhesion-deficiency 2026-05-04T12:52:13.000Z monthly 0.6 https://novapharmanews.com/us/news/fda-approves-foundayo-orforglipron-priority-voucher-program 2026-05-04T21:21:25.358Z monthly 0.6 https://novapharmanews.com/eu/news/ema-analysis-ai-pharma-rd-investment-2024 2026-05-04T22:11:51.483Z monthly 0.6 https://novapharmanews.com/eu/news/ema-accelerated-assessment-novel-mrna-vaccine-platforms-2024 2026-05-04T12:54:16.332Z monthly 0.6 https://novapharmanews.com/eu/news/ema-approval-gene-therapies-neurological-disorders-2024 2026-05-04T22:06:43.644Z monthly 0.6 https://novapharmanews.com/eu/news/ema-hta-regulation-impact-pharma-rd-2024 2026-05-04T20:44:58.614Z monthly 0.6 https://novapharmanews.com/eu/news/ema-clinical-trials-regulation-rare-disease-2026 2026-05-04T12:54:16.376Z monthly 0.6 https://novapharmanews.com/us/news/fda-approval-dermtech-skinguard-severe-eczema-2026 2026-05-04T02:55:39.055Z monthly 0.6 https://novapharmanews.com/eu/news/ema-blockchain-pharmaceutical-supply-chain-2024 2026-05-04T20:16:34.321Z monthly 0.6 https://novapharmanews.com/eu/news/ema-gdpr-impact-pharmaceutical-data-2024 2026-05-04T16:01:02.546Z monthly 0.6 https://novapharmanews.com/apac/news/nmpa-data-integrity-requirements-guide-2024 2026-05-04T11:51:12.038Z monthly 0.6 https://novapharmanews.com/us/news/fda-approval-cognimax-alzheimers-2026 2026-05-03T07:51:36.022Z monthly 0.6 https://novapharmanews.com/us/news/fda-approves-vitarestrore-age-related-macular-degeneration-2026 2026-05-04T12:36:15.747Z monthly 0.6 https://novapharmanews.com/us/news/fda-approves-nasoclear-pediatric-rsv-2026 2026-05-03T22:33:12.652Z monthly 0.6 https://novapharmanews.com/us/news/fda-approval-revitalize-chronic-fatigue-syndrome-2026 2026-05-04T14:10:54.076Z monthly 0.6 https://novapharmanews.com/eu/news/ema-ai-powered-clinical-trial-matching-patient-recruitment-2024 2026-05-04T12:54:16.459Z monthly 0.6 https://novapharmanews.com/eu/news/ema-regulatory-outlook-digital-therapeutics-europe-2024 2026-05-04T10:01:32.532Z monthly 0.6 https://novapharmanews.com/apac/news/nmpa-ai-clinical-trial-matching-china-2024 2026-05-04T10:35:37.317Z monthly 0.6 https://novapharmanews.com/apac/news/nmpa-telemedicine-apac-opportunities-challenges-2024 2026-05-04T06:59:14.951Z monthly 0.6 https://novapharmanews.com/us/news/fda-approves-genecorrect-gene-therapy-cystic-fibrosis-2026 2026-05-04T12:52:13.071Z monthly 0.6 https://novapharmanews.com/us/news/fda-approves-myorepair-breakthrough-therapy-2026 2026-05-04T12:52:02.167Z monthly 0.6 https://novapharmanews.com/us/news/fda-approval-oncoblock-refractory-aml-2024 2026-05-04T12:52:00.069Z monthly 0.6 https://novapharmanews.com/us/news/fda-approves-xylocor-nda-advanced-melanoma-2024 2026-05-04T04:20:26.578Z monthly 0.6 https://novapharmanews.com/us/news/fda-approves-repatha-evolocumab-cardiovascular-prevention-2024 2026-05-04T02:23:16.595Z monthly 0.6 https://novapharmanews.com/us/news/fda-approves-tecentriq-atezolizumab-es-sclc-2024 2026-05-04T12:53:11.610Z monthly 0.6 https://novapharmanews.com/us/news/fda-approves-opdivo-nivolumab-advanced-rcc-2024 2026-05-04T14:17:29.348Z monthly 0.6 https://novapharmanews.com/us/news/fda-approval-keytruda-adjuvant-stage-iii-melanoma-2024 2026-05-04T21:50:17.496Z monthly 0.6 https://novapharmanews.com/us/news/fda-approves-aduhelm-alzheimers-2021 2026-05-02T06:51:38.461Z monthly 0.6 https://novapharmanews.com/us/news/fda-approves-dupixent-eosinophilic-esophagitis-2024 2026-05-04T12:52:02.630Z monthly 0.6 https://novapharmanews.com/us/news/fda-approves-johnson-johnson-stelara-ulcerative-colitis-2024 2026-05-04T21:49:03.122Z monthly 0.6 https://novapharmanews.com/us/news/fda-approves-imfinzi-durvalumab-stage-iii-nsclc-2024 2026-05-04T16:47:59.429Z monthly 0.6 https://novapharmanews.com/us/news/fda-approves-trikafta-cystic-fibrosis-children-2024 2026-05-03T22:30:18.731Z monthly 0.6 https://novapharmanews.com/us/news/fda-approval-mounjaro-weight-management-2024 2026-05-04T13:37:43.069Z monthly 0.6 https://novapharmanews.com/us/news/fda-approves-cosentyx-hidradenitis-suppurativa-2024 2026-05-04T00:49:45.936Z monthly 0.6 https://novapharmanews.com/us/news/fda-approval-moderna-mrna-1345-rsv-vaccine-2024 2026-05-04T18:11:46.956Z monthly 0.6 https://novapharmanews.com/us/news/fda-approval-zithromax-pediatric-cap-2026 2026-05-04T20:05:31.969Z monthly 0.6 https://novapharmanews.com/us/news/fda-priority-review-revivcor-etanercept-biosimilar-heart-failure-2024 2026-05-04T12:50:34.443Z monthly 0.6 https://novapharmanews.com/apac/news/nmpa-breakthrough-innovent-kras-g12c-inhibitor-2024 2026-05-04T20:50:29.749Z monthly 0.6 https://novapharmanews.com/apac/news/pmda-accepts-shionogi-influenza-drug-sakigake-2024 2026-05-03T23:13:59.972Z monthly 0.6 https://novapharmanews.com/apac/news/cdsco-policy-changes-generics-market-growth-india-2024 2026-05-02T22:50:10.544Z monthly 0.6 https://novapharmanews.com/apac/news/pmda-sakigake-designation-regenerative-medicine-market-access-2024 2026-05-04T04:44:36.583Z monthly 0.6 https://novapharmanews.com/apac/news/nmpa-priority-review-pathway-innovative-drug-approvals-2024 2026-05-04T22:21:05.011Z monthly 0.6 https://novapharmanews.com/us/news/fda-approves-lumasiran-acute-hepatic-porphyria-2026 2026-05-04T23:00:29.375Z monthly 0.6 https://novapharmanews.com/us/news/fda-approval-inhalex-copd-2026 2026-04-18T10:45:53.078Z monthly 0.6 https://novapharmanews.com/us/news/fda-approval-rapiclot-tranexamic-acid-trauma-2026 2026-05-04T12:52:02.197Z monthly 0.6 https://novapharmanews.com/us/news/fda-approval-tarzenta-advanced-her2-negative-breast-cancer-2024 2026-05-04T12:49:25.890Z monthly 0.6 https://novapharmanews.com/us/news/fda-approval-ritempro-parkinsons-2026 2026-05-03T00:05:10.047Z monthly 0.6 https://novapharmanews.com/apac/news/pmda-expedited-review-novel-melanoma-therapies-2024 2026-05-04T22:34:40.557Z monthly 0.6 https://novapharmanews.com/apac/news/tga-innovation-report-australian-biotech-solid-tumor-car-t-2024 2026-05-04T05:05:54.053Z monthly 0.6 https://novapharmanews.com/us/news/fda-approves-tevimbra-tislelizumab-escc-2024 2026-05-04T12:40:07.618Z monthly 0.6 https://novapharmanews.com/us/news/fda-approves-wainua-eplontersen-hattr-pn-2024 2026-05-04T18:19:58.638Z monthly 0.6 https://novapharmanews.com/us/news/fda-approves-sanofi-altuviiio-hemophilia-a-2024 2026-05-04T11:19:14.683Z monthly 0.6 https://novapharmanews.com/us/news/fda-approval-augtyro-repotrectinib-ros1-nsclc-2024 2026-05-04T13:57:50.269Z monthly 0.6 https://novapharmanews.com/us/news/fda-approval-litfulo-ritlecitinib-alopecia-2024 2026-04-18T09:43:05.126Z monthly 0.6 https://novapharmanews.com/apac/news/nmpa-gmp-standards-foreign-manufacturers-impact-2024 2026-05-03T11:51:56.894Z monthly 0.6 https://novapharmanews.com/eu/news/mhra-vs-ema-regulatory-pathway-strategy-2024 2026-05-04T20:02:41.841Z monthly 0.6 https://novapharmanews.com/eu/news/ema-accelerated-assessment-rare-disease-therapies-2026 2026-05-04T12:00:23.130Z monthly 0.6 https://novapharmanews.com/eu/news/ema-market-analysis-orphan-drug-pricing-reimbursement-2024 2026-05-04T19:37:10.649Z monthly 0.6 https://novapharmanews.com/apac/news/nmpa-accelerated-approval-orphan-drugs-impact-future-trends-2024 2026-05-04T09:00:56.474Z monthly 0.6 https://novapharmanews.com/apac/news/ich-guidelines-biosimilar-development-apac-2024 2026-05-04T19:22:29.930Z monthly 0.6 https://novapharmanews.com/apac/news/cdsco-forecasting-biosimilar-market-growth-india-2024 2026-05-04T21:40:45.421Z monthly 0.6 https://novapharmanews.com/apac/news/tga-pmda-uptake-adalimumab-biosimilars-2024 2026-05-04T21:08:41.764Z monthly 0.6 https://novapharmanews.com/apac/news/pmda-biosimilar-framework-trastuzumab-adoption-2024 2026-05-04T09:13:32.563Z monthly 0.6 https://novapharmanews.com/apac/news/nmpa-biosimilar-approval-pathway-analysis-2024 2026-05-04T18:14:24.363Z monthly 0.6 https://novapharmanews.com/us/news/fda-approves-repatha-pediatric-hefh-2024 2026-05-04T12:52:02.408Z monthly 0.6 https://novapharmanews.com/us/news/fda-approves-adzynma-thrombotic-thrombocytopenic-purpura-2024 2026-05-04T20:53:41.393Z monthly 0.6 https://novapharmanews.com/us/news/fda-approval-otc-naloxone-nasal-spray-opioid-overdose-2024 2026-05-04T22:31:20.123Z monthly 0.6 https://novapharmanews.com/us/news/fda-priority-review-sotorasib-kras-g12c-nsclc-2024 2026-05-04T20:51:44.976Z monthly 0.6 https://novapharmanews.com/us/news/fda-approves-veozah-fezolinetant-menopause-2024 2026-05-03T10:54:32.968Z monthly 0.6 https://novapharmanews.com/apac/news/nmpa-pmda-tga-pompe-disease-market-analysis-2024 2026-05-03T22:22:29.377Z monthly 0.6 https://novapharmanews.com/us/news/fda-approval-omidubicel-onlv-2026 2026-05-04T16:08:59.763Z monthly 0.6 https://novapharmanews.com/us/news/fda-approves-updated-covid19-vaccines-fall-2024 2026-05-04T19:28:51.593Z monthly 0.6 https://novapharmanews.com/us/news/fda-approves-bosulif-pediatric-cml-2024 2026-05-04T01:44:43.924Z monthly 0.6 https://novapharmanews.com/us/news/fda-approves-ztalmy-ganaxolone-cdkl5-deficiency-2024 2026-05-04T17:09:06.232Z monthly 0.6 https://novapharmanews.com/eu/news/ema-impact-eu-pharmaceutical-strategy-api-manufacturing-2024 2026-05-04T21:05:25.295Z monthly 0.6 https://novapharmanews.com/us/news/fda-approves-opdivo-nivolumab-gastric-cancer-2024 2026-05-04T12:52:02.374Z monthly 0.6 https://novapharmanews.com/us/news/fda-approval-breyanzi-car-t-mantle-cell-lymphoma-2024 2026-05-04T02:22:56.081Z monthly 0.6 https://novapharmanews.com/us/news/fda-accelerated-approval-mirvetuximab-soravtansine-elahere-2026 2026-05-04T21:43:40.169Z monthly 0.6 https://novapharmanews.com/us/news/fda-approval-elarek-osteoporosis-prevention-2026 2026-05-04T01:28:42.982Z monthly 0.6 https://novapharmanews.com/apac/news/pmda-sakigake-designation-expedited-drug-approval-2024 2026-05-04T21:45:16.600Z monthly 0.6 https://novapharmanews.com/apac/news/nmepa-accelerated-approvals-policy-changes-2024 2026-05-04T11:07:32.576Z monthly 0.6 https://novapharmanews.com/eu/news/ema-legislation-reform-market-access-innovation-2024 2026-05-04T09:01:45.567Z monthly 0.6 https://novapharmanews.com/apac/news/nmpa-approval-bevacizumab-biosimilar-china-2024 2026-05-03T21:00:41.102Z monthly 0.6 https://novapharmanews.com/eu/news/ema-marketing-authorization-denosumab-biosimilar-2024 2026-05-04T17:02:51.584Z monthly 0.6 https://novapharmanews.com/us/news/fda-approval-interchangeable-biosimilar-ustekinumab-2024 2026-05-04T22:30:22.336Z monthly 0.6 https://novapharmanews.com/eu/news/chmp-positive-opinion-car-t-therapy-relapsed-b-cell-lymphoma-2024 2026-05-04T20:13:39.699Z monthly 0.6 https://novapharmanews.com/eu/news/ema-legislation-reform-biopharma-innovation-2024 2026-05-04T22:04:51.885Z monthly 0.6 https://novapharmanews.com/apac/news/tga-australia-early-phase-trials-analysis-2024 2026-05-04T01:17:15.951Z monthly 0.6 https://novapharmanews.com/eu/news/ema-artificial-intelligence-clinical-trials-guidelines-2024 2026-05-04T15:06:19.452Z monthly 0.6 https://novapharmanews.com/us/news/fda-approval-anti-inflammatory-atopic-dermatitis-2024 2026-05-04T15:58:23.931Z monthly 0.6 https://novapharmanews.com/us/news/fda-approval-amgen-bispecific-antibody-colorectal-cancer-2024 2026-05-04T21:39:11.939Z monthly 0.6 https://novapharmanews.com/us/news/fda-approval-syfovre-geographic-atrophy-2023 2026-04-28T22:01:03.334Z monthly 0.6 https://novapharmanews.com/us/news/fda-approves-endeavorrx-digital-therapeutic-adhd-2024 2026-05-04T14:38:17.811Z monthly 0.6 https://novapharmanews.com/us/news/fda-approval-roche-ntrk-fusion-therapy-2024 2026-05-04T12:52:13.600Z monthly 0.6 https://novapharmanews.com/us/news/fda-approves-casgevy-gene-therapy-sickle-cell-2023 2026-05-04T13:49:52.532Z monthly 0.6 https://novapharmanews.com/us/news/fda-approval-humira-biosimilar-interchangeable-2023 2026-05-04T12:50:34.491Z monthly 0.6 https://novapharmanews.com/us/news/fda-approval-gilead-hiv-bimonthly-treatment-2024 2026-05-03T15:04:21.720Z monthly 0.6 https://novapharmanews.com/us/news/fda-priority-review-astrazeneca-wilson-disease-2024 2026-05-03T18:53:03.226Z monthly 0.6 https://novapharmanews.com/us/news/fda-accelerated-approval-donanemab-alzheimers-2024 2026-05-03T08:30:06.383Z monthly 0.6 https://novapharmanews.com/us/news/fda-approves-novartis-breast-cancer-treatment-2024 2026-05-04T11:14:58.280Z monthly 0.6 https://novapharmanews.com/us/news/fda-approves-lumakras-nsclc-2023 2026-04-30T01:28:22.483Z monthly 0.6 https://novapharmanews.com/us/news/fda-approves-talquetamab-multiple-myeloma-2024 2026-05-04T12:59:02.491Z monthly 0.6